查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
預充式註射器市場,產業趨勢和全球預測（~2035）:按註射器用途,治療領域,分子類型,針筒材料,腔室數量,針頭系統,注射器可用性,注射器類型,包裝類型和主要地區
市場調查報告書
商品編碼
1439186

預充式註射器市場,產業趨勢和全球預測（~2035）:按註射器用途,治療領域,分子類型,針筒材料,腔室數量,針頭系統,注射器可用性,注射器類型,包裝類型和主要地區

Prefilled Syringes Market, Industry Trends & Global Forecasts, till 2035: Distribution by Purpose of Syringe, Therapeutic Area, Type of Molecule, Barrel Material, Number of Barrel Chamber, Needle System, Key Geographical Regions
出版日期: | 出版商: Roots Analysis | 英文 867 Pages | 商品交期: 最快1-2個工作天內

價格

預充式註射器的市場規模預計到 2024 年將達到 30 億美元，並預計在 2024-2035 年預測期內複合年增長率為 4.6%。

近年來，類風濕性關節炎等自體免疫疾病,心血管疾病,糖尿病,腫瘤疾病等多種慢性疾病的盛行率在全球範圍內顯著增加。 光是在美國，預計到 2022 年就有近 1.33 億人患有一種或多種慢性病，預計到 2030 年將增加至 1.7 億人。 根據美國疾病管制中心 (CDC) 最近的一項研究，美國每年與慢性疾病相關的費用負擔為 4.1 兆美元。 這些費用的很大一部分來自於頻繁用藥的需要，這導致定期去醫院就診。 此外，由於隱私問題或不適，患者不願在臨床環境中接受注射是另一個挑戰，影響患者對治療方案的依從性。

為了應對這些挑戰，人們開發了多種自動注射器，包括自動注射器,預充填式註射器和筆式註射器。 預充式註射器尤其受到青睞，尤其是在過敏性休克和類風濕性關節炎治療等緊急情況下。 這些注射器預先填充了精確數量的腸外藥物，無需手動填充。 優點包括方便,劑量準確,降低污染風險和減少藥物浪費。 透過減少患者就診醫療機構的次數，預充式註射器有助於降低全球醫療保健成本。 目前，預充式註射器有多種類型，包括雙室預充式註射器,沖洗注射器以及具有防止針刺傷機構的安全注射器。 由於越來越多地採用自註射注射器,持續的技術進步以及對家庭醫療保健服務的日益偏好，預計全球預充式註射器市場在短期內將出現顯著增長。

本報告調查了全球預充式註射器市場，並按註射器用途,治療領域,分子類型,針筒材料,腔室數量,針頭系統和注射器可用性對市場進行了概述。按註射器類型,包裝類型,重點區域和進入市場的公司概況劃分的趨勢。

目錄

第一章前言

第二章研究方法

第 3 章經濟與其他專案特定考量

第 4 章執行摘要

第 5 章簡介

第六章預灌封注射器:市場概論

第七章產品競爭力分析

第八章公司簡介:北美預灌封注射器製造商

第 9 章公司簡介:歐洲預灌封注射器製造商

第 10 章公司簡介:亞太地區預灌封注射器製造商

第 11 章 針刺傷

第十二章預充式註射器的監管狀況

  • 章節概述
  • 北美
  • 加拿大
  • 歐洲
  • 亞太地區
  • 其他領域

第十三章預灌封注射器組合產品

第14章主要治療領域

  • 章節概述
  • 自體免疫疾病
  • 傳染病
  • 神經系統疾病

第 15 章預充式註射器:候選藥物分析

第 16 章組合產品:大規模製藥活動

第 17 章近期進展

第十八章專利分析

第19章KOL分析

第20章 特殊預灌封注射器

第21章預充式註射器相關技術的進步

第22章主要生長促進因子

第23章SWOT分析

第24章全球預灌封注射器市場

第 25 章預灌封注射器市場，依注射器用途劃分

第 26 章預灌封注射器市場，依分子類型

第 27 章預灌封注射器市場，依治療領域劃分

第 28 章預灌封注射器市場，依管筒材料劃分

第 29 章預充式註射器市場，依腔室數量劃分

第 30 章預灌封注射器市場（依針頭系統）

第31章預灌封注射器市場，注射器的供應

第 32 章預灌封注射器市場，依注射器類型劃分

第 33 章預灌封注射器市場，依包裝類型

第34章預灌封注射器市場，依主要地區劃分

第35章血液疾病預灌封注射器市場

第36章傳染病預灌封注射器市場

第37章自體免疫疾病預灌封注射器市場

第38章腫瘤疾病預灌封注射器市場

第39章心血管疾病預灌封注射器市場

第40章呼吸系統疾病預灌封注射器市場

第41章神經系統疾病預灌封注射器市場

第 42 章代謝性疾病預充式註射器市場

第43章眼科疾病預灌封注射器市場

第44章骨科預灌封注射器市場

第45章其他疾病的預灌封注射器市場

第四十六章預灌封注射器組件製造商

第 47 章 預灌封注射器填充/整理服務提供者

第 48 章案例研究:自動注射器

第 49 章結論

第 50 章高階主管洞察力

第 51 章附錄 1:表格資料

第52章附錄2:公司與組織名單

Product Code: RA100347

Prefilled Syringes Market (7th Edition), Industry Trends and Global Forecasts, till 2035: Distribution by Purpose of Syringe (Specialty Prefilled Syringes, Therapeutic Prefilled Syringes and Cosmetic Prefilled Syringes), Therapeutic Area (Therapeutic Syringes - Blood Disorders, Infectious Diseases, Autoimmune Disorders, Oncological Disorders, Cardiovascular Disorders, Respiratory Disorders, Neurological Disorders, Metabolic Disorders, Ophthalmic Disorders, Orthopedic Disorders and Others), Type of Molecule (Therapeutic Syringes - Proteins, Antibodies, Peptides, Small Molecules, Vaccines and Cell Therapies), Type of Barrel Material (Glass Syringes and Plastic Syringes), Number of Barrel Chamber (Single Chamber Syringes and Dual Chamber Syringes), Type of Needle System (Staked Needle Syringes and Luer Syringes), Usability of Syringe (Disposable Syringes and Reusable Syringes), Type of Syringe (Conventional Syringes and Safety Syringes), Type of Packaging (Bulk Syringes and Nested Syringes) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America)

The prefilled syringes market is valued at USD 3 billion in 2024 growing at a CAGR of 4.6% during the forecast period 2024-2035.

The prevalence of various chronic disorders, such as autoimmune disorders like rheumatoid arthritis, cardiovascular disorders, diabetes, and oncological disorders, has seen a significant rise globally in recent years. In the US alone, it is estimated that close to 133 million individuals suffered from one or more chronic disorders in 2022, a number projected to increase to 170 million by 2030. According to a recent study by the US Centers for Disease Control (CDC), the annual cost burden associated with chronic disorders in the US amounts to USD 4.1 trillion. A considerable portion of these expenses stem from the frequent need for medication, leading to regular hospital visits. Additionally, patient reluctance to receive injections in clinical settings due to privacy concerns or discomfort poses another challenge, affecting patient compliance with treatment regimens.

To address these challenges, various self-administering devices, including autoinjectors, prefilled syringes, and pen injectors, have been developed. Prefilled syringes, in particular, have gained traction, especially in emergency situations like anaphylactic shock and rheumatoid arthritis treatment. These syringes are pre-loaded with precise doses of parenteral medication, eliminating the need for manual filling. They offer advantages such as convenience, dose precision, reduced risk of contamination, and minimal drug wastage. By reducing the number of patient visits to healthcare providers, prefilled syringes help lower global healthcare costs. Currently, various types of prefilled syringes are available, including dual chamber prefilled syringes, flush syringes, and safety syringes equipped with mechanisms to prevent needlestick injuries. With the increasing adoption of self-injecting parenteral devices, ongoing technological advancements, and growing preference for home healthcare services, the global prefilled syringes market is expected to witness significant growth in the foreseeable future.

Key Market Segments

Purpose of Syringe

Specialty Prefilled Syringes

Therapeutic Prefilled Syringes

Cosmetic Prefilled Syringes

Therapeutic Area (Therapeutic Syringes)

Blood Disorders

Infectious Diseases

Autoimmune Disorders

Oncological Disorders

Cardiovascular Disorders

Respiratory Disorders

Neurological Disorders

Metabolic Disorders

Ophthalmic Disorders

Orthopedic Disorders

Others

Type of Molecule (Therapeutic Syringes)

Proteins

Antibodies

Peptides

Small Molecules

Vaccines

Cell Therapies

Type of Barrel Material

Glass Syringe

Plastic Syringe

Number of Barrel Chamber

Single Chamber Syringe

Dual Chamber Syringe

Type of Needle System

Staked Needle Syringe

Luer Syringe

Usability of Syringe

Disposable Syringe

Reusable Syringe

Type of Syringe

Conventional Syringe

Safety Syringe

Type of Packaging

Bulk Syringe

Nested Syringe

Key Geographical Regions

North America

Europe

Asia-Pacific

Middle East and North Africa

Latin America

Research Coverage:

The report studies the prefilled syringe market based on purpose of syringe, therapeutic area, type of molecule, type of barrel material, number of barrel chamber, type of needle system, usability of syringe, type of syringe, type of packaging and key geographical regions.

The report assesses the potential advantages and obstacles within the market for those involved and offers information on the competitive environment for top players in the market.

The report forecasts the revenue of market segments with respect to five major regions

This chapter offers a comprehensive overview of prefilled syringes, including their components, historical development, and associated advantages. It also presents details on various types of prefilled syringes categorized by barrel fabrication material, number of barrel chambers, type of needle system, and packaging method. Additionally, the manufacturing process for prefilled syringes is outlined, along with future prospects for this industry.

A comprehensive evaluation of the current market landscape for prefilled syringes is conducted, considering various relevant parameters such as the type of barrel fabrication material, number of barrel chambers, type of needle system, and syringe volume. Additionally, the chapter provides an in-depth analysis of prefilled syringe manufacturers, including details on their establishment year, company size in terms of employee count, headquarters location, manufacturing facility location, and identification of the most active players based on the number of prefilled syringes manufactured.

Detailed company competitiveness evaluation of prefilled syringe manufacturers, considering manufacturer strength and product strength in terms of stage of development, number of barrel chambers and volume of syringe available and number of types of needle system.

Elaborate profiles of notable prefilled syringe manufacturers, selected based on our proprietary criteria and located in North America, Europe, and the Asia Pacific region, are presented. Each profile includes a succinct company overview featuring establishment year, headquarters location, employee count, and leadership team details. Financial information, if accessible, is also provided alongside the manufacturer's prefilled syringe portfolio, recent advancements, and an insightful future outlook. Additionally, profiles of other prominent players in the prefilled syringe industry are included, offering company overviews and details regarding their prefilled syringe product lineup.

The chapter addresses the increasing concern surrounding needlestick injuries and outlines the measures taken, including both regional and global legislations, to mitigate these incidents. It also presents comprehensive details on the safety features incorporated into recent iterations of prefilled syringes, including both add-on and integrated devices. Furthermore, it highlights the companies actively involved in the development and manufacturing of these safety solutions.

A comprehensive summary of guidelines set forth by major regulatory bodies for the approval of prefilled syringes across diverse countries and geographical regions.

A comprehensive analysis on various combination products available or under evaluation in prefilled syringe form, with a primary focus on injectable drugs and vaccines. This analysis encompasses detailed examinations of approved drugs based on pertinent parameters including the type of drug molecule, year of approval, region of approval, route of administration, and target therapeutic area. Furthermore, it includes analyses of products in clinical stages, considering parameters such as the type of drug molecule, phase of development, route of administration, and target therapeutic area. Additionally, the chapter provides insights into drug developers involved in the development of these products, including details on their establishment year, company size, headquarters location, and manufacturing facility location.

A comprehensive examination on the prevalent therapeutic indications commonly targeted in medical treatment. This discussion includes detailed information on approved or marketed injectable drug products utilized for the management of various clinical conditions across different therapeutic areas. Additionally, insights are provided on the availability of biosimilars for these drugs.

A thorough examination on marketed drugs or therapies expected to be accessible in prefilled syringe format in the near future. This analysis is based on various pertinent parameters, including historical annual sales data, type of drug molecule, therapeutic area, route of administration, and other existing dosage forms.

An assessment on the prefilled syringe combination product-related initiatives initiated by major pharmaceutical companies, selected based on their revenue generation in 2022. This review considers multiple parameters including the number of prefilled syringe combination products, both approved and under development, their target therapeutic areas, and the type of drug molecule utilized in these products.

An analysis of partnerships established in this sector, covering various relevant parameters such as year of initiative, type of initiative, geographical distribution and most active players.

An analysis on patents associated with prefilled syringes, filed or granted since 2019. This analysis considers various parameters such as the type of patent, publication year, application year, type of applicant, geographical location, CPC symbols, and the most active players in terms of the number of patents filed or granted. Additionally, the chapter includes patent benchmarking and a detailed patent valuation analysis, focusing on leading patents based on the number of citations received. An analysis is conducted to identify key opinion leaders (KOLs) in the prefilled syringes domain, considering parameters such as their role, sponsoring organization type, affiliated organization, target indication, and geographical location. The chapter also highlights prominent KOLs based on proprietary scoring criteria.

Detailed information is provided on specialty syringes, including prefilled flush syringes, prefilled diluent systems, and prefilled syringes with contrast agents. Each type of specialty syringe is briefly described, along with available products in the market and their respective advantages.

Recent technological advancements in prefilled syringe design and manufacturing are extensively discussed, focusing on enabling pharmaceutical companies to market lyophilized drugs in dual-chambered syringe systems. Novel lubrication and sterilization technologies are also highlighted.

A thorough examination on factors expected to drive growth in the prefilled syringes market, including the increase in chronic diseases, preference for self-administration of medications, evolving patient landscape, adoption of biologics and biosimilars, evolving pharmaceutical strategies, initiatives for needlestick injury prevention, and various potential applications of prefilled syringes.

Industry-affiliated trends, opportunities, and challenges are discussed under a SWOT analysis, emphasizing their potential impact on the evolution of the prefilled syringes market. A Harvey ball analysis is included to illustrate the relative impact of each SWOT parameter on industry dynamics.

The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth

Key Benefits of Buying this Report

The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.

Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.

The report provides stakeholders with a pulse on the prefilled syringes market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Key Market Companies

Becton Dickinson and Company

Credence MedSystems

Gerresheimer

J.O.Pharma

Medefil

MedXL

Mitsubishi Gas Chemical

Nipro PharmaPackaging

Novartis

Pfizer

SCHOTT

Shandong Pharmaceutical Glass

Shandong Weigao

Shin Yan Sheno Precision Industrial

Stevanato

Taisei Kako

Vetter Pharma

West Pharmaceutical

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Prefilled Syringes Market
  • 1.2. Market Share Insights
    • 1.2.1 Market Segmentation Overview
  • 1.3. Key Market Insights
  • 1.4. Report Coverage
  • 1.5. Key Questions Answered
  • 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

  • 2.1. Chapter Overview
  • 2.2. Research Assumptions
  • 2.3. Project Methodology
  • 2.4. Forecast Methodology
  • 2.5. Robust Quality Control
  • 2.6. Key Market Segmentations
  • 2.7. Key Considerations
    • 2.7.1. Demographics
    • 2.7.2. Economic Factors
    • 2.7.3. Government Regulations
    • 2.7.4. Supply Chain
    • 2.7.5. COVID Impact / Related Factors
    • 2.7.6. Market Access
    • 2.7.7. Healthcare Policies
    • 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

  • 3.1. Chapter Overview
  • 3.2. Market Dynamics
    • 3.2.1. Time Period
      • 3.2.1.1. Historical Trends
      • 3.2.1.2. Current and Forecasted Estimates
    • 3.2.2. Currency Coverage
      • 3.2.2.1. Overview of Major Currencies Affecting the Market
      • 3.2.2.2. Impact of Currency Fluctuations on the Industry
    • 3.2.3. Foreign Exchange Impact
      • 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
      • 3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
    • 3.2.4. Recession
      • 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
      • 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
    • 3.2.5. Inflation
      • 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
      • 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

  • 5.1. Chapter Overview
  • 5.2. History of Prefilled Syringes
  • 5.3. Benefits of Prefilled Syringes Over Traditional Injectable Devices
    • 5.3.1. Benefits of Prefilled Syringes for Healthcare Professionals and End Users
    • 5.3.2. Benefits of Prefilled Syringes for Manufacturers
    • 5.3.3. Transition from Existing Dosing Forms to Prefilled Syringes
  • 5.4. Prefilled Syringe Components
  • 5.5. Classification of Prefilled Syringes
    • 5.5.1. Classification based on Barrel Fabrication Material
      • 5.5.1.1. Glass Barrel Prefilled Syringes
        • 5.5.1.1.1. Limitations of Glass Barrel Prefilled Syringes
        • 5.5.1.1.2. Addressing the Limitations of Glass Barrel Prefilled Syringes
      • 5.5.1.2. Plastic Barrel Prefilled Syringes
        • 5.5.1.2.1. Limitations of Plastic Barrel Prefilled Syringes
        • 5.5.1.2.2. Addressing the Limitations of Plastic Barrel Prefilled Syringes
        • 5.5.1.2.3. Factors Likely to Drive the Use of Plastic Prefilled Syringes
    • 5.5.2. Classification based on Number of Chambers in the Barrel
    • 5.5.3. Classification based on Type of Needle
    • 5.5.4. Classification based on Type of Packaging
  • 5.6. Critical Attributes of Prefilled Syringe Design
  • 5.7. Key Manufacturing Steps for Prefilled Syringes
    • 5.7.1. Production of Barrels
      • 5.7.1.1. Glass Barrels
      • 5.7.1.2. Plastic Barrels
    • 5.7.2. Production of Syringes
    • 5.7.3. Barrel Siliconization
    • 5.7.4. Syringe Sterilization
    • 5.7.5. Validation of Sterilization
    • 5.7.6. Syringe Filling
    • 5.7.7. Syringe Testing
  • 5.8. Future Perspectives

6. PREFILLED SYRINGES: MARKET OVERVIEW

  • 6.1. Chapter Overview
  • 6.2. Prefilled Syringes: Overall Market Landscape
    • 6.2.1. Analysis by Type of Barrel Fabrication Material
    • 6.2.2. Analysis by Number of Barrel Chambers
    • 6.2.3. Analysis by Type of Needle System
    • 6.2.4. Analysis by Volume of Syringe
  • 6.3. Prefilled Syringes Manufacturers: Overall Market Landscape
    • 6.3.1. Analysis by Year of Establishment
    • 6.3.2. Analysis by Company Size
    • 6.3.3. Analysis by Location of Headquarters
    • 6.3.4. Analysis by Company Size and Location of Headquarters
    • 6.3.5. Analysis by Location of Manufacturing Facilities
    • 6.3.6. Most Active Players: Analysis by Number of Prefilled Syringes

7. PRODUCT COMPETITIVENESS ANALYSIS

  • 7.1. Chapter Overview
  • 7.2. Assumptions and Key Parameters
  • 7.3. Methodology
  • 7.4. Product Competitiveness Analysis: Prefilled Syringes
    • 7.4.1. Glass Barrel Prefilled Syringes
    • 7.4.2. Plastic Barrel Prefilled Syringes

8. COMPANY PROFILES: PREFILLED SYRINGE MANUFACTURERS IN NORTH AMERICA

  • 8.1. Chapter Overview
  • 8.2. Detailed Company Profiles of Leading Prefilled Syringe Manufacturers
    • 8.3.1 Becton, Dickinson and Company
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Information
      • 8.3.1.3. Becton, Dickinson and Company Prefilled Syringes Portfolio
      • 8.3.1.4. Recent Developments and Future Outlook
    • 8.3.2. Medefil
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Medefil Prefilled Syringes Portfolio
      • 8.3.2.3. Recent Developments and Future Outlook
    • 8.3.3. West Pharmaceutical
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Information
      • 8.3.3.2. West Pharmaceutical Prefilled Syringes Portfolio
      • 8.3.3.3. Recent Developments and Future Outlook
  • 8.4. Short Profiles of Other Prominent Prefilled Syringe Manufacturers
    • 8.4.1. Medline
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Prefilled Syringes Portfolio
    • 8.4.2. MedXL
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Prefilled Syringes Portfolio
    • 8.4.3 Pfizer
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Prefilled Syringes Portfolio

9. COMPANY PROFILES: PREFILLED SYRINGE MANUFACTURERS IN EUROPE

  • 9.1. Chapter Overview
  • 9.2. Detailed Company Profiles of Leading Prefilled Syringe Manufacturers
    • 9.3.1. Gerresheimer
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Information
      • 9.3.1.3. Gerresheimer Prefilled Syringes Portfolio
      • 9.3.1.4. Recent Developments and Future Outlook
    • 9.3.2 SCHOTT
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Information
      • 9.3.2.3. Schott Prefilled Syringes Portfolio
      • 9.3.2.4. Recent Developments and Future Outlook
    • 9.3.3. Stevanato
      • 9.3.3.1. Company Overview
      • 9.3.2.2. Financial Information
      • 9.3.3.3. Stevanato Prefilled Syringes Portfolio
      • 9.3.3.4. Recent Developments and Future Outlook
  • 9.4. Short Profiles of Other Prominent Prefilled Syringe Manufacturers
    • 9.4.1 B. Braun
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Prefilled Syringes Portfolio
    • 9.4.2. Nipro Europe
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Prefilled Syringes Portfolio
    • 9.4.3. Vetter Pharma
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Prefilled Syringes Portfolio

10. COMPANY PROFILES: PREFILLED SYRINGE MANUFACTURERS IN ASIA-PACIFIC

  • 10.1. Chapter Overview
  • 10.2. Detailed Company Profiles of Leading Prefilled Syringe Manufacturers
    • 10.2.1 Shandong Zibo Minkang Pharmaceutical Packing
      • 10.2.1.1. Company Overview
      • 10.2.1.2. Shandong Zibo Minkang Pharmaceutical Packing Prefilled Syringes Portfolio
      • 10.2.1.3. Recent Developments and Future Outlook
    • 10.2.2. Shin Yan Sheno Precision Industrial
      • 10.2.2.1. Company Overview
      • 10.2.2.2. Taisei Kako Prefilled Syringes Portfolio
      • 10.2.2.3. Recent Developments and Future Outlook
    • 10.2.3. Taisei Kako
      • 10.2.3.1. Company Overview
      • 10.2.3.2. Taisei Kako Prefilled Syringes Portfolio
      • 10.2.3.3. Recent Developments and Future Outlook
  • 10.3. Short Profiles of Other Prominent Prefilled Syringe Manufacturers
    • 10.3.1 J.O.Pharma
      • 10.3.1.1. Company Overview
      • 10.3.1.2. Prefilled Syringes Portfolio
    • 10.3.2. Shandong Pharmaceutical Glass
      • 10.3.2.1. Company Overview
      • 10.3.2.2. Prefilled Syringes Portfolio
    • 10.3.3. Shandong Weigao Group Medical Polymer
      • 10.3.3.1. Company Overview
      • 10.3.3.2. Prefilled Syringes Portfolio

11. NEEDLESTICK INJURIES

  • 11.1. Chapter Overview
  • 11.2. Incidence and Associated Financial Burden
  • 11.3. Government Legislations for Prevention of Needlestick Injuries
  • 11.4. Safety Mechanisms used in Modern Prefilled Syringes
    • 11.4.1. Safety Systems: Add-On Safety Device Manufacturers
      • 11.4.1.1. Becton Dickinson and Company
      • 11.4.1.2. Nemera
      • 11.4.1.3. Nipro PharmaPackagin
      • 11.4.1.4. Terumo
      • 11.4.1.5. West Pharmaceutical
    • 11.4.2. Safety Systems: Integrated Safety Device Manufacturers
      • 11.4.2.1. Gerresheimer
      • 11.4.2.2. Injecto
      • 11.4.2.3. MedicalChain International
      • 11.4.2.4. Stevanato
      • 11.4.2.5. Owen Mumford
      • 11.4.2.6. SHL Group
      • 11.4.2.7. Taisei Kako

12. REGULATORY LANDSCAPE FOR PREFILLED SYRINGES

  • 12.1. Chapter Overview
  • 12.2. Regulatory Approval of Combination Products in North America
    • 12.2.1. Regulatory Approval of Combination Products in the US
      • 12.2.1.1. Overview
      • 12.2.1.2. Historical Background
      • 12.1.1.3. Role of Regulatory Bodies in Product Approval
      • 12.1.1.4. Regulatory Approval of Prefilled Syringes
        • 12.1.1.4.1. Reimbursement Landscape in the US
        • 12.1.1.4.2. Payer Mix

12.1.1.4.3.. Reimbursement Process in the US

    • 12.2.2. Regulatory Approval of Combination Products in Canada
      • 12.2.2.1. Overview
      • 12.2.2.2. Role of Regulatory Bodies in Product Approval
      • 12.2.2.3. Regulatory Approval for Prefilled Syringes
        • 12.2.2.3.1. Reimbursement Landscape in Canada
        • 12.2.2.3.2. Payer Mix
        • 12.2.2.3.3. Reimbursement Process in Canada
  • 12.3. Regulatory Approval of Combination Products in Europe
    • 12.3.1. Overview
    • 12.3.2. Role of Regulatory Bodies in Product Approval
    • 12.3.3. Regulatory Approval of Prefilled Syringes
    • 12.3.4. Regulatory Approval of Combination Products in the UK
      • 12.3.4.1. Reimbursement Landscape in the UK
      • 12.3.4.2. Payer Mix
      • 12.3.4.3. Reimbursement Process in the UK
    • 12.3.5. Regulatory Approval of Combination Products in France
      • 12.3.5.1. Reimbursement Landscape in France
      • 12.3.5.2. Payer Mix
      • 12.3.5.3. Reimbursement Process in France
    • 12.3.6. Regulatory Approval of Combination Products in Spain
      • 12.3.6.1. Reimbursement Landscape in Spain
      • 12.3.6.2. Payer Mix
      • 12.3.6.3. Reimbursement Process in Spain
    • 12.3.7. Regulatory Approval of Combination Products in Spain
      • 12.3.7.1. Reimbursement Landscape in Germany
      • 12.3.7.2. Payer Mix
      • 12.3.7.3. Reimbursement Process in Germany
    • 12.3.8. Regulatory Approval of Combination Products in Italy
      • 12.3.8.1. Reimbursement Landscape in Italy
      • 12.3.8.2. Payer Mix
      • 12.3.8.3. Reimbursement Process in Italy
  • 12.4. Regulatory Approval of Combination Products in Asia-Pacific
    • 12.4.1. Regulatory Approval of Combination Products in Japan
      • 12.4.1.1 Overview
      • 12.4.1.2 Role of Regulatory Bodies in Product Approval
      • 12.4.1.3. Regulatory Approval of Prefilled Syringes
        • 12.4.1.3.1. Reimbursement Landscape in Japan
        • 12.4.1.3.2. Payer Mix
        • 12.4.1.3.3. Reimbursement Process in Japan
    • 12.4.2. Regulatory Approval of Combination Products in China
      • 12.4.2.1. Overview
      • 12.4.2.2. Role of Regulatory Bodies in Product Approval
      • 12.4.2.3. Regulatory Approval for Prefilled syringes
        • 12.4.2.3.1. Reimbursement Landscape in China
        • 12.4.2.3.2. Payer Mix
        • 12.4.2.3.3. Reimbursement Process in China
    • 12.4.3. Regulatory Approval of Combination Products in India
      • 12.4.3.1. Overview
      • 12.4.3.2. Role of Regulatory Bodies in Product Approval
      • 12.4.3.3. Regulatory Approval of Prefilled Syringes
        • 12.4.3.3.1. Reimbursement Landscape in India
        • 12.4.3.3.2. Payer Mix
    • 12.4.4. Regulatory Approval of Combination Products in South Korea
      • 12.4.4.1. Overview
      • 12.4.4.2. Role of Regulatory Bodies in Product Approval
      • 12.4.4.3. Regulatory Approval of Prefilled Syringes
        • 12.4.4.3.1. Reimbursement Landscape in South Korea
        • 12.4.4.3.2. Payer Mix
        • 12.4.4.3.3. Reimbursement Process in South Korea
    • 12.4.5. Regulatory Approval of Combination Products in Saudi Arabia
      • 12.4.5.1. Overview
      • 12.4.5.2. Role of Regulatory Bodies in Product Approval
      • 12.4.5.3. Regulatory Approval of Prefilled syringes
        • 12.4.5.3.1. Reimbursement Landscape in Saudi Arabia
        • 12.4.5.3.2. Payer Mix
        • 12.4.5.3.3. Reimbursement Process in Saudi Arabia
    • 12.4.6. Regulatory Approval of Combination Products in United Arab Emirates
      • 12.4.6.1. Overview
      • 12.4.6.2. Role of Regulatory Bodies in Product Approval
      • 12.4.6.3. Regulatory Approval of Prefilled syringes
        • 12.4.6.3.1. Reimbursement Landscape in United Arab Emirates
        • 12.4.6.3.2. Payer Mix
        • 12.4.6.3.3. Reimbursement Process in United Arab Emirates
  • 12.5. Regulatory Approval of Combination Products in Rest of the World
    • 12.5.1. Regulatory Approval of Combination Products in Brazil
      • 12.5.1.1 Overview
      • 12.5.1.2 Role of Regulatory Bodies in Product Approval
      • 12.5.1.3. Regulatory Approval of Prefilled Syringes
        • 12.5.1.3.1. Reimbursement Landscape in Brazil
        • 12.5.1.3.2. Payer Mix
        • 12.5.1.3.3. Reimbursement Process in Brazil
    • 12.5.2. Regulatory Approval of Combination Products in Australia
      • 12.5.2.1 Overview
      • 12.5.2.2 Role of Regulatory Bodies in Product Approval
      • 12.5.2.3. Regulatory Approval of Prefilled Syringes
        • 12.5.2.3.1. Reimbursement Landscape in Australia
        • 12.5.2.3.2. Payer Mix
        • 12.5.2.3.3. Reimbursement Process in Australia

13. PREFILLED SYRINGE COMBINATION PRODUCTS

  • 13.1. Chapter Overview
  • 13.2. Prefilled Syringe Combination Products: Approved Drugs
    • 13.2.1. Analysis by Type of Drug Molecule
    • 13.2.2. Analysis by Product Approval
    • 13.2.3. Analysis by Route of Administration
    • 13.2.4. Analysis by Target Therapeutic Area
    • 13.2.5. Analysis by Region of Product Analysis
    • 13.2.6. Analysis by Other Approved Primary Packaging Systems
  • 13.3. Prefilled Syringe Combination Products: Clinical Stage Drugs
    • 13.3.1. Analysis by Type of Drug Molecule
    • 13.3.2. Analysis by Phase of Development
    • 13.3.3. Analysis by Route of Administration
    • 13.3.4. Analysis by Target Therapeutic Area
  • 13.4. Prefilled Syringe Combination Products: Developers Landscape
    • 13.4.1. Analysis by Year of Establishment
    • 13.4.2. Analysis by Company Size
    • 13.4.3. Analysis by Location of Headquarters
  • 13.5. Leading Drugs in Prefilled Syringe Format
  • 13.6. Other Drugs Available in Prefilled Syringe Format
  • 13.7. Most Popular Drug Available in Prefilled Syringe Format: Humira (adalimumab), AbbVie / Eisai
    • 13.7.1. Target Indications and Available Dosage Forms
    • 13.7.2. Shift from Vials to Prefilled Syringes
    • 13.7.3. Humira Annual Sales, FY 2010-FY 2022

14. KEY THERAPEUTIC AREAS

  • 14.1. Chapter Overview
  • 14.2. Autoimmune Disorders
    • 14.2.1. Approved Drugs
    • 14.2.2. Key Developments
    • 14.2.3. Upcoming / Commercialized Biosimilars for Autoimmune Drugs
  • 14.3. Infectious Diseases
    • 14.3.1. Approved Drugs
    • 14.3.2. Key Developments
  • 14.4. Neurological Disorders
    • 14.4.1. Approved Drugs
    • 14.4.2. Key Developments

15. PREFILLED SYRINGES: LIKELY DRUG CANDIDATES ANALYSIS

  • 15.1. Chapter Overview
  • 15.2. Likely Drug Candidates
    • 15.2.1. Assumption and Key Parameters
    • 15.2.2. Methodology
    • 15.2.3. Most Likely Candidates for Delivery via Prefilled Syringes
    • 15.2.4. Likely Candidates for Delivery via Prefilled Syringes
    • 15.2.5. Less Likely Candidates for Delivery Via Prefilled Syringe

16. COMBINATION PRODUCTS: BIG PHARMA ACTIVITY

  • 16.1. Chapter Overview
  • 16.2. Methodology
  • 16.3. Combination Products: Big Pharma Activity
    • 16.3.1. Analysis by Target Therapeutic Area
      • 16.3.1.1. Autoimmune Disorders
      • 16.3.1.2. Infectious Diseases
      • 16.3.1.3. Neurological Disorders
      • 16.3.1.4. Blood Disorders
      • 16.3.1.5. Oncological Disorders
    • 16.3.2. Analysis by Type of Molecule
      • 16.3.2.1. Antibodies
      • 16.3.2.2. Vaccines
      • 16.3.2.3. Proteins
      • 16.3.2.4. Peptides
      • 16.3.2.5. Small Molecules
      • 16.3.2.6. Other Biologics

17. RECENT DEVELOPMENTS

  • 17.1. Chapter Overview
  • 17.2. Prefilled Syringes: Recent Developments
  • 17.3. Analysis by Year of Initiative
  • 17.4. Analysis by Type of Initiative
  • 17.5. Analysis by Year and Type of Initiative
    • 17.5.1. Analysis by Location of Expansion
    • 17.5.2. Analysis by Type of Expansion
    • 17.5.3 Analysis by Type of Partnership
  • 17.6. Analysis by Geography
  • 17.7. Most Active Players: Distribution by Number of Recent Initiatives
  • 17.8. Analysis of Player by Type of Initiatives

18. PATENT ANALYSIS

  • 18.1. Chapter Overview
  • 18.2. Scope and Methodology
  • 18.3. Prefilled Syringes: Patent Analysis
    • 18.3.1. Analysis by Patent Publication Year
    • 18.3.2. Analysis by Type of Patent and Publication Year
    • 18.3.3. Analysis by Patent Application Year
    • 18.3.4. Analysis by Patent Jurisdiction
    • 18.3.5. Analysis by CPC Symbols
    • 18.3.6. Analysis by Type of Applicant
    • 18.3.7. Leading Players: Analysis by Number of Patents
    • 18.3.8. Leading Individual Assignees: Analysis by Number of Patents
  • 18.4. Prefilled Syringes: Patent Benchmarking Analysis
    • 18.4.1. Analysis by Patent Characteristics
  • 18.5. Prefilled Syringes: Patent Valuation Analysis
  • 18.6. Leading Patents by Number of Citations

19. KOL ANALYSIS

  • 19.1. Chapter Overview
  • 19.2. Assumption and Key Parameters
  • 19.3. Methodology
  • 19.4. Prefilled Syringes: Key Opinion Leaders
    • 19.4.1. Analysis by Role of KOL
    • 19.4.2. Analysis by Type of Sponsor Organization
    • 19.4.3. Analysis by Affiliated Organization
    • 19.4.4. Analysis by Target Disease Indication
    • 19.4.5. Analysis by Geographical Location
    • 19.4.6. Most Prominent KOLs: Analysis by Activeness, Expertise and Strength of KOL
    • 19.4.7. Most Prominent KOLs: Analysis by RA score

20. SPECIALTY PREFILLED SYRINGES

  • 20.1. Chapter Overview
  • 20.2. Prefilled Flush Syringes
    • 20.2.1. Overview
    • 20.2.2. Advantages of Prefilled Flush Syringes
    • 20.2.3. Prefilled Flush Syringes Available in the Market
  • 20.3. Prefilled Diluent Syringes
    • 20.3.1. Overview
    • 20.3.2. Advantages of Prefilled Diluent Syringes
    • 20.3.3. Lyophilized Drugs Available in Prefilled Diluent Syringes
  • 20.4. Contrast Agent Prefilled Syringes
    • 20.4.1. Overview
    • 20.4.2. Advantages of Using Prefilled Syringes for Contrast Agents
    • 20.4.3. Contrast Agents Available in Prefilled Syringes

21. TECHNOLOGICAL ADVANCES RELATED TO PREFILLED SYRINGES

  • 21.1. Chapter Overview
  • 21.2. Prefilled Syringes for Lyophilized Drugs
    • 21.2.1. Prefilled Diluent Syringes
    • 21.2.2. Prefilled Dual-Chamber Syringes
  • 21.3. Multilayer Plastic Prefilled Syringes with Oxygen Barrier
  • 21.4. Prefilled Syringes with Low Risk of Particle Formation
  • 21.5. Advanced Lubrication Technology for Prefilled Syringes
  • 21.6. Advances in Terminal Sterilization of Prefilled Syringes
  • 21.7. Prefilled Syringe Usage Aids for Patients and Healthcare Providers
  • 21.8. Additional Advancements

22. KEY GROWTH DRIVERS

  • 22.1. Chapter Overview
  • 22.2. Rising Incidence of Chronic Diseases
  • 22.3. Growing Preference for Self-Injection
  • 22.4. Evolving Patient Demographics
  • 22.5. Growth of Biologics and Biosimilars Market
  • 22.6. Changing Pharmaceutical Practices
  • 22.7. Increasing Focus on Prevention of Needlestick Injuries
  • 22.8. Prefilled Syringes in Autoinjectors and Pen Injectors

23. SWOT ANALYSIS

  • 23.1. Chapter Overview
  • 23.2. Strengths
    • 23.2.1. Ease of Use
    • 23.2.2. Ability to Reduce / Eliminate Medication Errors
    • 23.2.3. Reducing the Risk of Accidental Transmission of Blood-Borne Pathogens
    • 23.2.4. Economic Advantages
    • 23.2.5. Drug Life Cycle Management
  • 23.3. Weaknesses
    • 23.3.1. Manufacturing Complexities
    • 23.3.2. High Packaging and Transportation Costs
    • 23.3.3. Product Stability and Quality Related Issues
    • 23.3.4. Challenges Associated with Drug Filing
  • 23.4. Opportunities
    • 23.4.1. Rich and Growing Pipeline of Biologics and Biosimilars
    • 23.4.2. Growing Preference for Self-Injecting
    • 23.4.3. Application in Advanced Drug Delivery Devices
    • 23.4.4. Innovation in Design and Technical Advancement
    • 23.4.5. Rising Popularity across the Globe
    • 23.4.6. Widespread Use in Vaccination Programs
  • 23.5. Threats
    • 23.5.1. Material Compatibility Issues
    • 23.5.2. Availability of Alternative Drug Delivery Devices
    • 23.5.3. Concern Related to Numerous Product Recalls In Past
  • 23.6. Concluding Remarks

24. GLOBAL PREFILLED SYRINGES MARKET

  • 24.1. Chapter Overview
  • 24.2. Assumptions and Methodology
  • 24.3. Global Prefilled Syringes Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 24.3.1. Scenario Analysis
  • 24.4. Key Market Segmentations

25. PREFILLED SYRINGES MARKET, BY PURPOSE OF SYRINGE

  • 25.1. Chapter Overview
  • 25.2. Key Assumptions and Methodology
  • 25.3. Prefilled Syringes Market: Distribution by Purpose of Syringe, 2018, 2023 and 2035
    • 25.3.1. Specialty Prefilled Syringe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 25.3.2. Therapeutic Prefilled Syringe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 25.3.3. Cosmetic Prefilled Syringe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 25.4. Data Triangulation and Validation

26. PREFILLED SYRINGES MARKET, BY TYPE OF MOLECULE

  • 26.1. Chapter Overview
  • 26.2. Key Assumptions and Methodology
  • 26.3. Prefilled Syringes Market: Distribution by Type of Molecule, 2018, 2023 and 2035
    • 26.3.1. Prefilled Syringes Market for Proteins: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 26.3.2. Prefilled Syringes Market for Antibodies: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 26.3.3. Prefilled Syringes Market for Peptides: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 26.3.4. Prefilled Syringes Market for Small Molecules: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 26.3.5. Prefilled Syringes Market for Vaccines: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 26.3.6. Prefilled Syringes Market for Cell Therapies: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 26.4. Data Triangulation and Validation

27. PREFILLED SYRINGES MARKET, BY THERAPEUTIC AREA

  • 27.1. Chapter Overview
  • 27.2. Key Assumptions and Methodology
  • 27.3. Prefilled Syringes Market: Distribution by Therapeutic Area, 2018, 2023 and 2035
    • 27.3.1. Prefilled Syringes Market for Blood Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 27.3.2. Prefilled Syringes Market for Infectious Diseases: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 27.3.3. Prefilled Syringes Market for Autoimmune Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 27.3.4. Prefilled Syringes Market for Oncological Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 27.3.5. Prefilled Syringes Market for Cardiovascular Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 27.3.6. Prefilled Syringes Market for Respiratory Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 27.3.7. Prefilled Syringes Market for Neurological Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 27.3.8. Prefilled Syringes Market for Metabolic Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 27.3.9. Prefilled Syringes Market for Ophthalmic Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 27.3.10. Prefilled Syringes Market for Orthopedic Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 27.3.11 Prefilled Syringes Market for Other Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 27.4. Data Triangulation and Validation

28. PREFILLED SYRINGES MARKET, BY TYPE OF BARREL MATERIAL

  • 28.1. Chapter Overview
  • 28.2. Key Assumptions and Methodology
  • 28.3. Prefilled Syringes Market: Distribution by Type of Barrel Material, 2018, 2023 and 2035
    • 28.3.1. Glass Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 28.3.2. Plastic Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 28.4. Data Triangulation and Validation

29. PREFILLED SYRINGES MARKET, BY NUMBER OF CHAMBER

  • 29.1. Chapter Overview
  • 29.2. Key Assumptions and Methodology
  • 29.3. Prefilled Syringes Market: Distribution by Number of Chamber, 2018, 2023 and 2035
    • 29.3.1. Single Chamber Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 29.3.2. Dual Chamber Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 29.4. Data Triangulation and Validation

30. PREFILLED SYRINGES MARKET, BY TYPE OF NEEDLE SYSTEM

  • 30.1. Chapter Overview
  • 30.2. Key Assumptions and Methodology
  • 30.3. Prefilled Syringes Market: Distribution by Type of Needle System, 2018, 2023 and 2035
    • 30.3.1. Staked Needle Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 30.3.2. Luer Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 30.4. Data Triangulation and Validation

31. PREFILLED SYRINGES MARKET, BY USABILITY OF SYRINGE

  • 31.1. Chapter Overview
  • 31.2. Key Assumptions and Methodology
  • 31.3. Prefilled Syringes Market: Distribution by Usability of Syringe, 2018, 2023 and 2035
    • 31.3.1. Disposable Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 31.3.2. Reusable Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 31.4. Data Triangulation and Validation

32. PREFILLED SYRINGES MARKET, BY TYPE OF SYRINGE

  • 32.1. Chapter Overview
  • 32.2. Key Assumptions and Methodology
  • 32.3. Prefilled Syringes Market: Distribution by Type of Syringe, 2018, 2023 and 2035
    • 32.3.1. Conventional Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 32.3.1. Safety Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 32.4. Data Triangulation and Validation

33. PREFILLED SYRINGES MARKET, BY TYPE OF PACKAGING

  • 33.1. Chapter Overview
  • 33.2. Key Assumptions and Methodology
  • 33.3. Prefilled Syringes Market: Distribution by Type of Packaging, 2018, 2023 and 2035
    • 33.3.1. Bulk Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 33.3.2. Nested Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 33.4. Data Triangulation and Validation

34. PREFILLED SYRINGES MARKET, BY KEY GEOGRAPHICAL REGIONS

  • 34.1. Chapter Overview
  • 34.2. Key Assumptions and Methodology
  • 34.3. Prefilled Syringes Market: Distribution by Key Geographical Region, 2018, 2023 and 2035
    • 34.3.1 Prefilled Syringes Market in North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 34.3.2. Prefilled Syringes Market in Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 34.3.3. Prefilled Syringes Market in Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 34.3.4. Prefilled Syringes Market in Middle East and South Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 34.3.5 Prefilled Syringes Market in Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 34.4. Data Triangulation and Validation

35. PREFILLED SYRINGES MARKET, FOR BLOOD DISORDERS

  • 35.1. Chapter Overview
  • 35.2. Key Assumptions and Methodology
  • 35.3. Prefilled Syringes Market for Blood Disorders: Distribution by Type of Molecule
    • 35.3.1. Proteins Market for Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 35.3.2. Small Molecules Market for Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 35.4. Prefilled Syringes Market for Blood Disorders: Distribution by Type of Barrel Material
    • 35.4.1. Glass Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 35.4.2. Plastic Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 35.5. Prefilled Syringes Market for Blood Disorders: Distribution by Number of Chamber
    • 35.5.1. Single Chamber Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 35.5.2. Dual Chamber Prefilled Syringes, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 35.6. Prefilled Syringes Market for Blood Disorders: Distribution by Type of Needle System
    • 35.6.1. Staked Needle Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 35.6.2. Luer Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 35.7. Prefilled Syringes Market for Blood Disorders: Distribution by Usability of Syringe
    • 35.7.1. Disposable Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 35.7.2. Reusable Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 35.8. Prefilled Syringes Market for Blood Disorders: Distribution by Type of Syringe
    • 35.8.1. Conventional Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 35.8.2. Safety Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 35.9. Prefilled Syringes Market for Blood Disorders: Distribution by Type of Packaging
    • 35.9.1. Bulk Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 35.9.2. Nested Prefilled Syringes Market for Blood Disorders, Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
  • 35.10. Prefilled Syringes Market for Blood Disorders: Distribution by Key Geographical Region
    • 35.10.1. Prefilled Syringes Market for Blood Disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 35.10.2. Prefilled Syringes Market for Blood Disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 35.10.3. Prefilled Syringes Market for Blood Disorders in Asia- Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 35.10.4. Prefilled Syringes Market for Blood Disorders in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 35.10.5. Prefilled Syringes Market for Blood Disorders in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

36. PREFILLED SYRINGES MARKET, FOR INFECTIOUS DISEASES

36 Prefilled Syringes Market for Infectious Diseases

  • 36.1. Chapter Overview
  • 36.2. Key Assumptions and Methodology
  • 36.3. Prefilled Syringes Market for Infectious Diseases: Distribution by Type of Molecule
    • 36.3.1. Proteins Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 36.3.2. Vaccines Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 36.4. Prefilled Syringes Market for Infectious Diseases: Distribution by Type of Barrel Material
    • 36.4.1. Glass Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 36.4.2. Plastic Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 36.5. Prefilled Syringes Market for Infectious Diseases: Distribution by Number of Chamber
    • 36.5.1. Single Chamber Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 36.5.2. Dual Chamber Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 36.6. Prefilled Syringes Market for Infectious Diseases: Distribution by Type of Needle System
    • 36.6.1. Staked Needle Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 36.6.2. Luer Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 36.7. Prefilled Syringes Market for Infectious Diseases: Distribution by Usability of Syringe
    • 36.7.1. Disposable Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 36.7.2. Reusable Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 36.8. Prefilled Syringes Market for Infectious Diseases: Distribution by Type of Syringe
    • 36.8.1. Conventional Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 36.8.2. Safety Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 36.9. Prefilled Syringes Market for Infectious Diseases: Distribution by Type of Packaging
    • 36.9.1. Bulk Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 36.9.2. Nested Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
  • 36.10. Prefilled Syringes Market for Infectious Diseases: Distribution by Key Geographical Region
    • 36.10.1. Prefilled Syringes Market for Infectious Diseases in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 36.10.2. Prefilled Syringes Market for Infectious Diseases in Europe, Historical Trends (2018-2022) and Forecasted Estimates(2023-2035)
    • 36.10.3. Prefilled Syringes Market for Infectious Diseases in Asia-Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 36.10.4. Prefilled Syringes Market for Infectious Diseases in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 36.10.5. Prefilled Syringes Market for Infectious Diseases in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

37. PREFILLED SYRINGES MARKET, FOR AUTOIMMUNE DISORDERS

  • 37.1. Chapter Overview
  • 37.2. Key Assumptions and Methodology
  • 37.3. Prefilled Syringe Market for Autoimmune Disorders: Distribution by Type of Molecule
    • 37.3.1. Proteins Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 37.3.2. Antibodies Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 37.3.3. Peptides Market for Autoimmune Disorders, Historical Trends (2020-2022) and Forecasted Estimates (2023-2035)
    • 37.3.4. Small Molecule Market for Autoimmune Disorders, Historical Trends (2020-2022) and Forecasted Estimates (2023-2035)
  • 37.4. Prefilled Syringe Market for Autoimmune Disorders: Distribution by Type of Barrel Material
    • 37.4.1. Glass Barrel Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 37.4.2. Plastic Barrel Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 37.5. Prefilled Syringe Market for Autoimmune Disorders: Distribution by Number of Chamber
    • 37.5.1. Single Chamber Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 37.5.2. Dual Chamber Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 37.6. Prefilled Syringe Market for Autoimmune Disorders: Distribution by Type of Needle System
    • 37.6.1. Staked Needle Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 37.6.2. Luer Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 37.7. Prefilled Syringe Market for Autoimmune Disorders: Distribution by Usability of Syringe
    • 37.7.1. Disposable Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 37.7.2. Reusable Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 37.8. Prefilled Syringe Market for Autoimmune Disorders: Distribution by Type of Syringe
    • 37.8.1. Conventional Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 37.8.2. Safety Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
  • 37.9. Prefilled Syringe Market for Autoimmune Disorders: Distribution by Type of Packaging
    • 37.9.1. Bulk Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 37.9.2. Nested Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
  • 37.10. Prefilled Syringe Market for Autoimmune Disorders: Distribution by Key Geographical Region
    • 37.10.1. Prefilled Syringes Market for Autoimmune Disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 37.10.2. Prefilled Syringes Market for Autoimmune Disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 37.10.3. Prefilled Syringes Market for Autoimmune Disorders in Asia-Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 37.10.4. Prefilled Syringes Market for Autoimmune Disorders in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 37.10.5. Prefilled Syringes Market for Autoimmune Disorders in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

38. PREFILLED SYRINGES MARKET, FOR ONCOLOGICAL DISORDERS

  • 38.1. Chapter Overview
  • 38.2. Key Assumptions and Methodology
  • 38.3. Prefilled Syringe Market for Oncological disorders: Distribution by Type of Molecule
    • 38.3.1. Proteins Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 38.3.2. Antibodies Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 38.3.3. Peptides Market for Oncological Disorders, Historical Trends (2020-2022) and Forecasted Estimates (2023-2035)
    • 38.3.4. Small Molecules Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 38.3.5. Vaccines Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 38.4. Prefilled Syringe Market for Oncological disorders: Distribution by Type of Barrel Material
    • 38.4.1. Glass Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 38.4.2. Plastic Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 38.5. Prefilled Syringe Market for Oncological disorders: Distribution by Number of Chamber
    • 38.5.1. Single Chamber Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 38.5.2. Dual Chamber Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 38.6. Prefilled Syringe Market for Oncological disorders: Distribution by Type of Needle System
    • 38.6.1. Staked Needle Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 38.6.2. Luer Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 38.7. Prefilled Syringe Market for Oncological disorders: Distribution by Usability of Syringe
    • 38.7.1. Disposable Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 38.7.2. Reusable Barrel Prefilled Syringes, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 38.8. Prefilled Syringe Market for Oncological Disorders: Distribution by Type of Syringe
    • 38.8.1. Conventional Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 38.8.2. Safety Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 38.9. Prefilled Syringe Market for Oncological disorders: Distribution by Type of Packaging
    • 38.9.1. Bulk Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 38.9.2. Nested Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
  • 38.10. Prefilled Syringes Market for Oncological disorders: Distribution by Key Geographical Regions
    • 38.10.1. Prefilled Syringes Market for Oncological disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 38.10.2. Prefilled Syringes Market for Oncological disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 38.10.3. Prefilled Syringes Market for Oncological Disorders in Asia- Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 38.10.4. Prefilled Syringes Market for Oncological Disorders in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 38.10.5. Prefilled Syringes Market for Oncological Disorders in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

39. PREFILLED SYRINGES MARKET, FOR CARDIOVASCULAR DISORDERS

  • 39.1. Chapter Overview
  • 39.2. Key Assumptions and Methodology
  • 39.3. Prefilled Syringes Market for Cardiovascular Disorders: Distribution by Type of Molecule
    • 39.3.1. Antibodies Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 39.3.2. Cell Therapies Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 39.4. Prefilled Syringes Market for Cardiovascular disorders: Distribution by Type of Barrel Material
    • 39.4.1. Glass Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 39.4.2. Plastic Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 39.5. Prefilled Syringes Market for Cardiovascular disorders: Distribution by Number of Chamber
    • 39.5.1. Single Chamber Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 39.5.2. Dual Chamber Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 39.6. Prefilled Syringes Market for Cardiovascular disorders: Distribution by Type of Needle System
    • 39.6.1. Staked Needle Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 39.6.2. Luer Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 39.7. Prefilled Syringes Market for Cardiovascular disorders: Distribution by Usability of Syringe
    • 39.7.1. Disposable Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 39.7.2. Reusable Barrel Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 39.8. Prefilled Syringes Market for Cardiovascular disorders: Distribution by Type of Syringe
    • 39.8.1. Conventional Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 39.8.2. Safety Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 39.9. Prefilled Syringes Market for Cardiovascular Disorders: Distribution by Type of Packaging
    • 39.9.1. Bulk Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 39.9.2. Nested Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
  • 39.10. Prefilled Syringes Market for Cardiovascular Disorders: Distribution by Key Geographical Regions
    • 39.10.1. Prefilled Syringes Market for Cardiovascular Disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 39.10.2. Prefilled Syringes Market for Cardiovascular Disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 39.10.3. Prefilled Syringes Market for Cardiovascular Disorders in Asia-Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 39.10.4. Prefilled Syringes Market for Cardiovascular Disorders in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 39.10.5. Prefilled Syringes Market for Cardiovascular Disorders in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

40. PREFILLED SYRINGES MARKET, FOR RESPIRATORY DISORDERS

  • 40.1. Chapter Overview
  • 40.2. Key Assumptions and Methodology
  • 40.3. Prefilled Syringes Market for Respiratory disorders: Distribution by Type of Molecule
    • 40.3.1. Antibodies Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 40.4. Prefilled Syringes Market for Respiratory disorders: Distribution by Type of Barrel Material
    • 40.4.1. Glass Barrel Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 40.4.2. Plastic Barrel Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 40.5. Prefilled Syringes Market for Respiratory disorders: Distribution by Number of Chamber
    • 40.5.1. Single Chamber Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 40.5.2. Dual Chamber Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 40.6. Prefilled Syringes Market for Respiratory disorders: Distribution by Type of Needle System
    • 40.6.1. Staked Needle Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 40.6.2. Luer Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 40.7. Prefilled Syringes Market for Respiratory Disorders: Distribution by Usability of Syringe
    • 40.7.1. Disposable Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 40.7.2. Reusable Barrel Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 40.8. Prefilled Syringes Market for Respiratory Disorders: Distribution by Type of Syringe
    • 40.8.1. Conventional Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 40.8.2. Safety Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 40.9. Prefilled Syringes Market for Respiratory Disorders: Distribution by Type of Packaging
    • 40.9.1. Bulk Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 40.9.2. Nested Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
  • 40.10. Prefilled Syringes Market for Respiratory Disorders: Distribution by Key Geographical Regions
    • 40.10.1. Prefilled Syringes Market for Respiratory Disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 40.10.2. Prefilled Syringes Market for Respiratory Disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 40.10.3. Prefilled Syringes Market for Respiratory Disorders in Asia- Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 40.10.4. Prefilled Syringes Market for Respiratory Disorders in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 40.10.5. Prefilled Syringes Market for Respiratory Disorders in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

41. PREFILLED SYRINGES MARKET, FOR NEUROLOGICAL DISORDERS

  • 41.1. Chapter Overview
  • 41.2. Key Assumptions and Methodology
  • 41.3. Prefilled Syringes Market for Neurological Disorders: Distribution by Type of Molecule
    • 41.3.1. Antibodies Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 41.3.2. Proteins Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 41.3.3. Peptides Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 41.3.4. Small Molecules Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 41.4. Prefilled Syringes Market for Neurological Disorders: Distribution by Type of Barrel Material
    • 41.4.1. Glass Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 41.4.2. Plastic Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 41.5. Prefilled Syringes Market for Neurological Disorders: Distribution by Number of Chamber
    • 41.5.1. Single Chamber Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 41.5.2. Dual Chamber Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 41.6. Prefilled Syringes Market for Neurological Disorders: Distribution by Type of Needle System
    • 41.6.1. Staked Needle Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 41.6.2. Luer Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 41.7. Prefilled Syringes Market for Neurological Disorders: Distribution by Usability of Syringe
    • 41.7.1. Disposable Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 41.7.2. Reusable Barrel Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 41.8. Prefilled Syringes Market for Neurological Disorders: Distribution by Type of Syringe
    • 41.8.1. Conventional Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 41.8.2. Safety Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 41.9. Prefilled Syringes Market for Neurological Disorders: Distribution by Type of Packaging
    • 41.9.1. Bulk Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 41.9.2. Nested Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
  • 41.10. Prefilled Syringes Market for Neurological Disorders: Distribution by Key Geographical Regions
    • 41.10.1. Prefilled Syringes Market for Neurological Disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 41.10.2. Prefilled Syringes Market for Neurological Disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 41.10.3. Prefilled Syringes Market for Neurological Disorders in Asia-Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 41.10.4. Prefilled Syringes Market for Neurological Disorders in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 41.10.5. Prefilled Syringes Market for Neurological Disorders in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

42. PREFILLED SYRINGES MARKET, FOR METABOLIC DISORDERS

  • 42.1. Chapter Overview
  • 42.2. Key Assumptions and Methodology
  • 42.3. Prefilled Syringes Market for Metabolic Disorders: Distribution by Type of Molecule
    • 42.3.1. Proteins Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 42.3.2. Small Molecule Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 42.3.3. Peptides Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 42.4. Prefilled Syringes Market for Metabolic disorders: Distribution by Type of Barrel Material
    • 42.4.1. Glass Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 42.4.2. Plastic Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 42.5. Prefilled Syringes Market for Metabolic Disorders: Distribution by Number of Chamber
    • 42.5.1. Single Chamber Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 42.5.2. Dual Chamber Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 42.6. Prefilled Syringes Market for Metabolic Disorders: Distribution by Type of Needle System
    • 42.6.1. Staked Needle Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 42.6.2. Luer Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 42.7. Prefilled Syringes Market for Metabolic Disorders: Distribution by Usability of Syringe
    • 42.7.1. Disposable Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 42.7.2. Reusable Barrel Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 42.8. Prefilled Syringes Market for Metabolic Disorders: Distribution by Type of Syringe
    • 42.8.1. Conventional Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 42.8.2. Safety Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 42.9. Prefilled Syringes Market for Metabolic Disorders: Distribution by Type of Packaging
    • 42.9.1. Bulk Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 42.9.2. Nested Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
  • 42.10. Prefilled Syringes Market for Metabolic Disorders: Distribution by Key Geographical Regions
    • 42.10.1. Prefilled Syringes Market for Metabolic Disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 42.10.2. Prefilled Syringes Market for Metabolic Disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 42.10.3. Prefilled Syringes Market for Metabolic disorders in Asia- Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 42.10.4. Prefilled Syringes Market for Metabolic disorders in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 42.10.5. Prefilled Syringes Market for Metabolic disorders in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

43. PREFILLED SYRINGES MARKET, FOR OPHTHALMIC DISORDERS

  • 43.1. Chapter Overview
  • 43.2. Key Assumptions and Methodology
  • 43.3. Prefilled Syringes Market for Ophthalmic Disorders: Distribution by Type of Molecule
    • 43.3.1. Proteins Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 43.3.2. Antibodies for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 43.4. Prefilled Syringes Market for Ophthalmic Disorders: Distribution by Type of Barrel Material
    • 43.4.1. Glass Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 43.4.2. Plastic Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 43.5. Prefilled Syringes Market for Ophthalmic Disorders: Distribution by Number of Chamber
    • 43.5.1. Single Chamber Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 43.5.2. Dual Chamber Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 43.6. Prefilled Syringes Market for Ophthalmic Disorders: Distribution by Type of Needle System
    • 43.6.1. Staked Needle Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 43.6.2. Luer Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 43.7. Prefilled Syringes Market for Ophthalmic Disorders: Distribution by Usability of Syringe
    • 43.7.1. Disposable Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 43.7.2. Reusable Barrel Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
  • 43.8. Prefilled Syringes Market for Ophthalmic Disorders: Distribution by Type of Syringe
    • 43.8.1. Conventional Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 43.8.2. Safety Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 43.9. Prefilled Syringes Market for Ophthalmic Disorders: Distribution by Type of Packaging
    • 43.9.1. Bulk Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 43.9.2. Nested Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
  • 43.10. Prefilled Syringes Market for Ophthalmic disorders: Distribution by Key Geographical Regions
    • 43.10.1. Prefilled Syringes Market for Ophthalmic disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 43.10.2. Prefilled Syringes Market for Ophthalmic disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 43.10.3. Prefilled Syringes Market for Ophthalmic disorders in Asia- Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 43.10.4. Prefilled Syringes Market for Ophthalmic disorders in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 43.10.5. Prefilled Syringes Market for Ophthalmic disorders in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

44. PREFILLED SYRINGES MARKET, FOR ORTHOPEDIC DISORDERS

  • 44.1. Chapter Overview
  • 44.2. Key Assumptions and Methodology
  • 44.3. Prefilled Syringes Market for Orthopedic Disorders: Distribution by Type of Molecule
    • 44.3.1. Antibodies Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 44.3.2. Small Molecules Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 44.3.3. Cell Therapies Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 44.4. Prefilled Syringes Market for Orthopedic Disorders: Distribution by Type of Barrel Material
    • 44.4.1. Glass Barrel Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 44.4.2. Plastic Barrel Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 44.5. Prefilled Syringes Market for Orthopedic Disorders: Distribution by Number of Chamber
    • 44.5.1. Single Chamber Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 44.5.2. Dual Chamber Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 44.6. Prefilled Syringes Market for Orthopedic Disorders: Distribution by Type of Needle System
    • 44.6.1. Staked Needle Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 44.6.2. Luer Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 44.7. Prefilled Syringes Market for Orthopedic Disorders: Distribution by Usability of Syringe
    • 44.7.1. Disposable Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 44.7.2. Reusable Barrel Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 44.8. Prefilled Syringes Market for Orthopedic Disorders: Distribution by Type of Syringe
    • 44.8.1. Conventional Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 44.8.2. Safety Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
  • 44.9. Prefilled Syringes Market for Orthopedic Disorders: Distribution by Type of Packaging
    • 44.9.1. Bulk Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 44.9.2. Nested Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
  • 44.10. Prefilled Syringes Market for Orthopedic Disorders: Distribution by Key Geographical Regions
    • 44.10.1. Prefilled Syringes Market for Orthopedic disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 44.10.2. Prefilled Syringes Market for Orthopedic disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 44.10.3. Prefilled Syringes Market for Orthopedic disorders in Asia- Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 44.10.4. Prefilled Syringes Market for Orthopedic disorders in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 44.10.5. Prefilled Syringes Market for Orthopedic disorders in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

45. PREFILLED SYRINGES MARKET, FOR OTHER DISORDERS

  • 45.1. Chapter Overview
  • 45.2. Key Assumptions and Methodology
  • 45.3. Prefilled Syringes Market for Other Disorders: Distribution by Type of Molecule
    • 45.3.1. Proteins Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 45.3.2. Antibodies Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 45.3.3. Peptides Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 45.3.4. Small Molecules Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 45.3.5. Vaccines Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 45.3.6. Cell Therapies Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 45.4. Prefilled Syringes Market for Other Disorders: Distribution by Type of Barrel Material
    • 45.4.1. Glass Barrel Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 45.4.2. Plastic Barrel Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 45.5. Prefilled Syringes Market for Other Disorders: Distribution by Number of Chamber
    • 45.5.1. Single Chamber Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 45.5.2. Dual Chamber Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 45.6. Prefilled Syringes Market for Other Disorders: Distribution by Type of Needle System
    • 45.6.1. Staked Needle Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 45.6.2. Luer Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 45.7. Prefilled Syringes Market for Other Disorders: Distribution by Usability of Syringe
    • 45.7.1. Disposable Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 45.7.2. Reusable Barrel Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 45.8. Prefilled Syringes Market for Other Disorders: Distribution by Type of Syringe
    • 45.8.1. Conventional Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 45.8.2. Safety Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 45.9. Prefilled Syringes Market for Other Disorders: Distribution by Type of Packaging
    • 45.9.1. Bulk Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 45.9.2. Nested Prefilled Syringes Market for Other Disorders, Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
  • 45.10. Prefilled Syringes Market for Other Disorders: Distribution by Key Geographical Regions
    • 45.10.1. Prefilled Syringes Market for Other disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 45.10.2. Prefilled Syringes Market for Other disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 45.10.3. Prefilled Syringes Market for Other disorders in Asia- Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 45.10.5. Prefilled Syringes Market for Other disorders in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

46. PREFILLED SYRINGE COMPONENT MANUFACTURERS

  • 46.1. Chapter Overview
  • 46.2. List of Component Manufacturers
  • 46.3. Prominent Prefilled Syringe Component Manufacturers: Companies Profiled
    • 46.3.1. West Pharmaceutical Services
      • 46.3.1.1. Company Overview
      • 46.3.1.2. Financial Information
      • 46.3.1.3. Product Portfolio
      • 46.3.1.4. Recent Developments and Future Outlook
    • 46.3.2. Datwyler
      • 46.3.2.1. Company Overview
      • 46.3.2.2. Financial Information
      • 46.3.2.3. Product Portfolio
      • 46.3.2.4. Recent Developments and Future Outlook
    • 46.3.3. Aptar Pharma
      • 46.3.3.1. Company Overview
      • 46.3.3.2. Financial Information
      • 46.3.3.3. Product Portfolio
      • 46.3.3.4. Recent Developments and Future Outlook
    • 46.3.4. Stevanato
      • 46.3.4.1. Company Overview
      • 46.3.4.2. Financial Information
      • 46.3.4.3. Product Portfolio
      • 46.3.4.4. Recent Developments and Future Outlook

47. FILL / FINISH SERVICE PROVIDERS FOR PREFILLED SYRINGES

  • 47.1. Chapter Overview
  • 47.2. Fill / Finish Processing of Prefilled Syringes
    • 47.2.1. Steps Involved in Fill / Finish Process
    • 47.2.2. Methods of Filling and Stoppering of Prefilled Syringes
    • 47.2.3. Prefilled Syringe Filling Technologies
  • 47.3. Outsourcing of Fill / Finish Operations
  • 47.4. Growth Considerations
    • 47.4.1. Recent Developments
  • 47.5. Prefilled Syringes: Fill / Finish Service Providers
    • 47.5.1. Analysis by Year of Establishment
    • 47.5.2. Analysis by Location of Headquarters and Type of Molecule Filled
    • 47.5.3. Analysis by Scale of Operation

48. CASE STUDY: AUTOINJECTORS

  • 48.1. Chapter Overview
  • 48.2. Autoinjectors Compatible with Prefilled Syringes
  • 48.3. Key Players
    • 48.3.1. Owen Mumford
      • 48.3.1.1. Company Overview
      • 48.3.1.2. Product Portfolio
        • 48.3.1.2.1 Autoinjectors: Product Details
          • 48.3.1.2.1.1 Autoinjectors Micro
          • 48.3.1.2.1.2. Autoject 2
          • 48.3.1.2.1.3. Autoject Mini
          • 48.3.1.2.1.4. Autoject Visco
          • 48.3.1.2.1.5. Autoject Uni
          • 48.3.1.2.1.6. Autoject Multi
          • 48.3.1.2.1.7. Autoject Flex
          • 48.3.1.2.1.8. Unisafe Auto-injector
          • 48.3.1.2.1.9. Unisafe Connected Auto-injector
          • 48.3.1.2.1.10. Aidaptus
    • 48.3.2. Elcam Medical (E3D Elcam Drug Delivery Devices)
      • 48.3.2.1. Company Overview
      • 48.3.2.2. Product Portfolio
        • 48.3.2.2.1 Autoinjectors: Product Details
          • 48.3.2.2.1.1. Flexi-Q Disposable Autoinjectors
          • 48.3.2.2.1.2. Flexi-Q Reusable Autoinjectors
    • 48.3.3. Union Medico
      • 48.3.3.1. Company Overview
      • 48.3.3.2. Product Portfolio
        • 48.3.3.2.1. Autoinjectors: Product Details
          • 48.3.3.2.1.1. 45? Autoinjectors
          • 48.3.3.2.1.2. 90? Autoinjectors
          • 48.3.3.2.1.3. SuperGrip Autoinjectors
          • 48.3.3.2.1.4. Exclusive Autoinjectors
    • 48.3.4. SHL Group
      • 48.3.4.1. Company Overview
      • 48.3.4.2. Product Portfolio
        • 48.3.4.2.1. Autoinjectors: Product Details (Based on Compatible Device)
          • 48.3.4.2.1.1. Prefilled Syringe Based Autoinjectors
          • 48.3.4.2.1.2. Cartridge Based Autoinjectors
        • 48.3.4.2.2. Autoinjectors: Product Details (Based on Method of Preparation)
          • 48.3.4.2.2.1. Two-Step Disposable Autoinjectors: Product Details
    • 48.3.5. Ypsomed
      • 48.3.5.1. Company Overview
      • 48.3.5.2. Financial Information
      • 48.3.5.3. Product Portfolio
        • 48.3.5.3.1. Autoinjectors: Product Details
          • 48.3.5.3.1.1. YpsoMate Series
          • 48.3.5.3.1.2. VarioJect
          • 48.3.5.3.1.3. LyoTwist Series

49. CONCLUDING REMARKS

50. EXECUTIVE INSIGHTS

  • 50.1. Chapter Overview
  • 50.2. Oval Medical Technologies
    • 50.2.1. Company Snapshot
    • 50.2.2. Interview Transcript: Matthew Young, Founder and Chief Technology Officer
  • 50.3. Intas Pharmaceuticals
    • 50.3.1. Company Snapshot
    • 50.3.2. Interview Transcript: Kirti Maheshwari, Chief Technical Officer
  • 50.4. West Pharmaceutical
    • 50.4.1. Company Snapshot
    • 50.4.2. Interview Transcript: Tibor Hlobik, Senior Director and Kevin Cancelliere, Former Director, Pharmaceutical Delivery Systems Marketing
  • 50.5. Lonstroff
    • 50.5.1. Company Snapshot
    • 50.5.2. Interview Transcript: Marco Pederiva, Head of R&D and Product Strategy
  • 50.6. IDEO
    • 50.6.1. Company Snapshot
    • 50.6.2. Interview Transcript: Jesse Fourt, Senior Portfolio Director
  • 50.7. IDT Biologika
    • 50.7.1. Company Snapshot
    • 50.7.2. Interview Transcript: Gregor Kawaletz, Former Chief Commercial Officer
  • 50.8. Small Medical Device Company
    • 50.8.1. Interview Transcript: Anonymous, Chief Executive Officer

51. APPENDIX 1: TABULATED DATA

52. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Tables

  • Table 5.1 Drugs: Shifted from Vials to Prefilled Syringe Systems
  • Table 5.2 Components of Prefilled Syringes
  • Table 5.3 Classification of Prefilled Syringes
  • Table 5.4 Glass Barrel Prefilled Syringe Recalls
  • Table 5.5 Pharmaceutical Filling Lines: Steps Performed by Type of Packaging of Prefilled Syringe
  • Table 6.1 Prefilled Syringes: List of Products
  • Table 6.2 Prefilled Syringes: List of Manufacturers
  • Table 6.3 Prefilled Flush Syringes: List of Manufacturers
  • Table 8.1 Prefilled Syringe Manufacturers (North America): List of Companies Profiled
  • Table 8.2 Becton, Dickinson and Company: Company Snapshot
  • Table 8.3 Becton, Dickinson and Company: Prefilled Syringes Portfolio
  • Table 8.4 Becton, Dickinson and Company: Recent Developments and Future Outlook
  • Table 8.5 Medefil: Company Snapshot
  • Table 8.6 Medefil: Prefilled Syringes Portfolio
  • Table 8.7 Medefil: Recent Developments and Future Outlook
  • Table 8.8 West Pharmaceutical Services: Company Snapshot
  • Table 8.9 West Pharmaceutical Services: Prefilled Syringes Portfolio
  • Table 8.10 West Pharmaceutical Services: Recent Developments and Future Outlook
  • Table 8.11 Medline: Company Snapshot
  • Table 8.12 Medline: Prefilled Syringes Portfolio
  • Table 8.13 MedXL: Company Snapshot
  • Table 8.14 MedXL: Prefilled Syringes Portfolio
  • Table 8.15 Pfizer: Company Snapshot
  • Table 8.16 Pfizer: Prefilled Syringes Portfolio
  • Table 9.1 Prefilled Syringe Manufacturers (Europe): List of Companies Profiled
  • Table 9.2 Gerresheimer: Company Snapshot
  • Table 9.3 Gerresheimer: Prefilled Syringes Portfolio
  • Table 9.4 Gerresheimer: Recent Developments and Future Outlook
  • Table 9.5 SCHOTT: Company Snapshot
  • Table 9.6 SCHOTT: Prefilled Syringes Portfolio
  • Table 9.7 SCHOTT: Recent Developments and Future Outlook
  • Table 9.8 Stevanato: Company Snapshot
  • Table 9.9 Stevanato: Prefilled Syringes Portfolio
  • Table 9.10 Stevanato: Recent Developments and Future Outlook
  • Table 9.11 B. Braun: Company Snapshot
  • Table 9.12 B. Braun: Prefilled Syringes Portfolio
  • Table 9.13 Nipro Europe: Company Snapshot
  • Table 9.14 Nipro Europe: Prefilled Syringes Portfolio
  • Table 9.15 Vetter Pharma: Company Snapshot
  • Table 9.16 Vetter Pharma: Prefilled Syringes Portfolio
  • Table 10.1 Prefilled Syringe Manufacturers (Asia-Pacific): List of Companies Profiled
  • Table 10.2 Shandong Zibo Minkang Pharmaceutical Packing: Company Snapshot
  • Table 10.3 Shandong Zibo Minkang Pharmaceutical Packing: Prefilled Syringes Portfolio
  • Table 10.4 Shin Yan Sheno Precision Industrial: Company Snapshot
  • Table 10.5 Shin Yan Sheno Precision Industrial: Prefilled Syringes Portfolio
  • Table 10.6 Taisei Kako: Company Snapshot
  • Table 10.7 Taisei Kako: Prefilled Syringes Portfolio
  • Table 10.8 Taisei Kako: Recent Developments and Future Outlook
  • Table 10.9 J O. Pharma: Company Snapshot
  • Table 10.10 J O. Pharma: Prefilled Syringes Portfolio
  • Table 10.11 Shandong Pharmaceutical Glass: Company Snapshot
  • Table 10.12 Shandong Pharmaceutical Glass: Prefilled Syringes Portfolio
  • Table 10.13 Shandong Weigao Group Medical Polymer: Company Snapshot
  • Table 10.14 Shandong Weigao Group Medical Polymer: Prefilled Syringes Portfolio
  • Table 11.1 Safety System: List of Add-on Safety Device Manufacturers
  • Table 11.2 Safety System: List of Integrated Safety Device Manufacturers
  • Table 12.1 FDA Center for Drug and Device Approval
  • Table 12.2 Regulatory Review Timelines for Combination Products in the US
  • Table 12.3 Data Requirements and Characteristics of Province-wide HTA Processes in Canada
  • Table 12.4 Regulatory Bodies in EU5 Countries
  • Table 12.5 Device Classification: Japan
  • Table 12.6 Medical Device Reimbursement Categories
  • Table 12.7 Device Classification: India
  • Table 12.8 Device Classification: South Korea
  • Table 12.9 Saudi Arabia: Regulatory Review Timelines
  • Table 12.10 Device Classification: Brazil
  • Table 12.11 Reimbursement and Pricing Approval Process of Prefilled Syringes in Australia
  • Table 13.1 Prefilled Syringe Combination Products: List of Approved Drugs, 2013-2022
  • Table 13.2 Prefilled Syringe Combination Products: Information on Approval Year and Region of Product Approval, 2013-2023
  • Table 13.3 Prefilled Syringe Combination Products: Information on Other Approved Primary Packaging Systems
  • Table 13.4 Prefilled Syringe Combination Products: Information on Dosage Strength
  • Table 13.5 Prefilled Syringe Combination Products: List of Clinical Stage Drugs
  • Table 13.6 Prefilled Syringe Combination Products: List of Developers
  • Table 13.7 List of Other Drugs Available in Prefilled Syringes Format
  • Table 14.1 Autoimmune Disorders: List of Leading Approved Drugs, 2022
  • Table 14.2 Autoimmune Disorders: Information on Patent Expiry and Biosimilar Developed for Drugs in Prefilled Syringe Format
  • Table 14.3 Infectious Diseases: List of Leading Approved Drugs, 2022
  • Table 14.4 Neurological Disorders: List of Leading Approved Drugs, 2022
  • Table 15.1 Most Likely Candidates for Delivery via Prefilled Syringes
  • Table 15.2 Likely Candidates for Delivery via Prefilled Syringes
  • Table 15.3 Less Likely Candidates for Delivery via Prefilled Syringes
  • Table 17.1 Prefilled Syringes: List of Recent Developments, 2019-2023
  • Table 18.1 Patent Analysis: Top CPC Sections
  • Table 18.2 Patent Analysis: Top CPC Symbols
  • Table 18.3 Patent Analysis: Top CPC Codes
  • Table 18.4 Patent Analysis: Summary of Benchmarking Analysis
  • Table 18.5 Patent Analysis: Categorization based on Weighted Valuation Scores
  • Table 18.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
  • Table 18.5 Patent Portfolio: List of Leading Patents (by Number of Citations)
  • Table 19.1 Prefilled Syringes: List of Key Opinion leaders
  • Table 20.1 List of Prefilled Flush Syringes Available in the Market
  • Table 20.2 List of Lyophilized Drugs Available with Prefilled Diluent Syringe System
  • Table 20.3 Contrast Agents Available in Prefilled Syringes
  • Table 21.1 List of Marketed Dual-Chamber Prefilled Syringes
  • Table 22.1 Fraction of Global Population above 60 years, for 2022, 2030 and 2050 (in Millions)
  • Table 22.2 List of Approved Autoinjector, 2016-2023
  • Table 22.3 Marketed Autoinjectors / Pen-Injectors with Prefilled Syringes
  • Table 23.1 List of Marketed / Pipeline Needleless Injection Devices
  • Table 23.2 List of Prefilled Syringe Recalls, 2003-2023
  • Table 46.1 Prefilled Syringe Component Manufacturers: List of Prefilled Syringe Component Manufacturers
  • Table 46.2 Prominent Prefilled Syringes Component Manufacturers: List of Companies Profiled
  • Table 46.3 West Pharmaceutical Services: Company Snapshot
  • Table 46.4 West Pharmaceutical Services: Product Portfolio
  • Table 46.5 Datwyler: Company Snapshot
  • Table 46.6 Datwyler: Product Portfolio
  • Table 46.7 Datwyler: Recent Developments and Future Outlook
  • Table 46.8 Aptar Pharma: Company Snapshot
  • Table 46.9 Aptar Pharma: Product Portfolio
  • Table 46.10 Aptar Pharma: Recent Developments and Future Outlook Future Outlook
  • Table 46.11 Stevanato: Company Snapshot
  • Table 46.12 Stevanato: Product Portfolio
  • Table 47.1 Prefilled Syringes: List of Fill / Finish Service Providers
  • Table 48.1 List of Autoinjectors (Using Prefilled Syringes)
  • Table 50.1 Oval Medical Technologies: Company Snapshot
  • Table 50.2 Intas Pharmaceuticals: Company Snapshot
  • Table 50.3 West Pharmaceutical: Company Snapshot
  • Table 50.4 Lonstroff: Company Snapshot
  • Table 50.5 IDEO: Company Snapshot
  • Table 50.6 IDT Biologika: Company Snapshot
  • Table 51.1 Prefilled Syringes: Distribution by Type of Barrel Fabrication Material
  • Table 51.2 Prefilled Syringes: Distribution by Number of Barrel Chambers
  • Table 51.3 Prefilled Syringes: Distribution by Type of Needle System
  • Table 51.4 Prefilled Syringes: Distribution by Volume of Syringe
  • Table 51.5 Prefilled Syringe Manufacturers: Distribution by Year of Establishment
  • Table 51.6 Prefilled Syringe Manufacturers: Distribution by Company Size
  • Table 51.7 Prefilled Syringe Manufacturers: Distribution by Location of Headquarters
  • Table 51.8 Prefilled Syringe Manufacturers: Distribution by Company Size and Location of Headquarters
  • Table 51.9 Prefilled Syringe Manufacturer: Distribution by Location of Manufacturing Facilities
  • Table 51.10 Most Active Players: Distribution by Number of Prefilled Syringes
  • Table 51.11 Becton, Dickinson and Company: Annual Revenues, FY 2015-9M FY 2023 (USD Million)
  • Table 51.12 Becton, Dickinson and Company: Distribution of Revenues by Business Divisions, FY 2022
  • Table 51.13 West Pharmaceutical Services: Annual Revenues, FY 2015-H1 FY 2023 (USD Million)
  • Table 51.14 West Pharmaceutical Services: Distribution of Revenues by Business Divisions, FY 2022
  • Table 51.15 Gerresheimer: Annual Revenues, FY 2015-H1 FY 2023 (EUR Million)
  • Table 51.16 Gerresheimer: Distribution of Revenues by Business Divisions, FY 2022
  • Table 51.17 SCHOTT: Annual Revenues, FY 2015-FY 2022 (EUR Million)
  • Table 51.18 SCHOTT: Distribution of Revenues by Business Divisions, FY 2022
  • Table 51.19 Stevanato: Annual Revenues, FY 2020-H1 FY 2023 (EUR Million)
  • Table 51.20 Stevanato: Distribution of Revenues by Business Divisions, FY 2022
  • Table 51.21 Approved Prefilled Syringe Combination Products: Distribution by Type of Drug Molecule Stored
  • Table 51.22 Approved Prefilled Syringe Combination Products: Distribution by Approval Year
  • Table 51.23 Approved Prefilled Syringe Combination Products: Distribution by Route of Administration
  • Table 51.24 Approved Prefilled Syringe Combination Products: Distribution by Target Therapeutic Area
  • Table 51.25 Approved Prefilled Syringe Combination Products: Distribution by Region of Product Approval
  • Table 51.26 Approved Prefilled Syringe Combination Products: Distribution by Other Approved Primary Packaging System
  • Table 51.27 Clinical Stage Prefilled Syringe Combination Products: Distribution by Type of Drug Molecule Stored
  • Table 51.28 Clinical Stage Prefilled Syringe Combination Products: Distribution by Phase of Development
  • Table 51.29 Clinical Stage Prefilled Syringe Combination Products: Distribution by Route of Administration
  • Table 51.30 Clinical Stage Prefilled Syringe Combination Products: Distribution by Target Therapeutic Area
  • Table 51.31 Prefilled Syringe Combination Product Developers: Distribution by Year of Establishment
  • Table 51.32 Prefilled Syringe Combination Product Developers: Distribution by Company Size
  • Table 51.33 Prefilled Syringe Combination Product Developers: Distribution by Location of Headquarters
  • Table 51.34 Sales of Leading Drugs Available in Prefilled Syringe Format, 2022 (USD Billion)
  • Table 51.35 Humira: Annual Sales, FY 2010-FY 2022 (USD Million)
  • Table 51.36 Recent Developments: Cumulative Year-wise Trend, 2019-2023
  • Table 51.37 Recent Developments: Distribution by Type of Initiative
  • Table 51.38 Recent Developments: Distribution by Year and Type of Initiative, 2019-2023
  • Table 51.39 Recent Developments: Distribution by Type of Expansion
  • Table 51.40 Recent Developments: Distribution by Location of Expansion
  • Table 51.41 Recent Developments: Distribution by Type of Partnership
  • Table 51.42 Recent Developments: Distribution by Geography
  • Table 51.43 Most Active Players: Distribution by Number of Recent Initiatives
  • Table 51.44 Most Active Players: Distribution by Type of Initiative
  • Table 51.45 Patent Analysis: Distribution by Type of Patent
  • Table 51.46 Patent Analysis: Cumulative Distribution by Patent Publication Year, 2019-2023
  • Table 51.47 Patent Analysis: Distribution by Type of Patent and Publication Year, 2019-2023
  • Table 51.48 Patent Analysis: Distribution by Patent Application Year, Pre-2014-2023
  • Table 51.49 Patent Analysis: Distribution by Geography
  • Table 51.50 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant, 2019-2023
  • Table 51.51 Leading Players: Distribution by Number of Patents
  • Table 51.52 Leading Individual Assignees: Distribution by Number of Patents
  • Table 51.53 Patent Analysis: Distribution by Patent Age
  • Table 51.54 Prefilled Syringes KOL Analysis: Distribution by Type of KOL
  • Table 51.55 Prefilled Syringes KOL Analysis: Distribution by Type of Sponsor Organization
  • Table 51.56 Prefilled Syringes KOL Analysis: Distribution by Affiliated Organization
  • Table 51.57 Prefilled Syringes KOL Analysis: Distribution by Target Disease Indication
  • Table 51.58 Prefilled Syringes KOL Analysis: Distribution by Geographical Location of KOL
  • Table 51.59 Most Prominent KOLs: Distribution by RA Score
  • Table 51.60 Global Prefilled Syringes Market, Historical Trends (2018-2022) (USD Million)
  • Table 51.61 Global Prefilled Syringes Market, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.62 Prefilled Syringes Market: Distribution by Purpose of Prefilled Syringe, 2018, 2023 and 2035 (USD Million)
  • Table 51.63 Specialty Prefilled Syringes, Historical Trends (2018-2022) (USD Million)
  • Table 51.64 Specialty Prefilled Syringes, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.65 Therapeutic Prefilled Syringes, Historical Trends (2018-2022) (USD Million)
  • Table 51.66 Therapeutic Prefilled Syringes, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.67 Cosmetic Prefilled Syringes, Historical Trends (2018-2022) (USD Million)
  • Table 51.68 Cosmetic Prefilled Syringes, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.69 Prefilled Syringes Market: Distribution by Type of Molecule, 2018, 2023 and 2035
  • Table 51.70 Prefilled Syringes Market for Proteins, Historical Trends (2018-2022) (USD Million)
  • Table 51.71 Prefilled Syringes Market for Proteins, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USDMillion)
  • Table 51.72 Prefilled Syringes Market for Antibodies, Historical Trends (2018-2022) (USD Million)
  • Table 51.73 Prefilled Syringes Market for Antibodies, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USDMillion)
  • Table 51.74 Prefilled Syringes Market for Peptides, Historical Trends (2018-2022) (USD Million)
  • Table 51.75 Prefilled Syringes Market for Peptides, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USDMillion)
  • Table 51.76 Prefilled Syringes Market for Small Molecules, Historical Trends (2018-2022) (USD Million)
  • Table 51.77 Prefilled Syringes Market for Small Molecules, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario(USD Million)
  • Table 51.78 Prefilled Syringes Market for Vaccines, Historical Trends (2018-2022) (USD Million)
  • Table 51.79 Prefilled Syringes Market for Vaccines, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USDMillion)
  • Table 51.80 Prefilled Syringes Market for Cell Therapies, Historical Trends (2018-2022) (USD Million)
  • Table 51.81 Prefilled Syringes Market for Cell Therapies, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario(USD Million)
  • Table 51.82 Prefilled Syringes Market: Distribution by Therapeutic Area, 2018, 2023 and 2035
  • Table 51.83 Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.84 Prefilled Syringes Market for Blood Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario(USD Million)
  • Table 51.85 Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) (USD Million)
  • Table 51.86 Prefilled Syringes Market for Infectious Diseases, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.87 Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.88 Prefilled Syringes Market for Autoimmune Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.89 Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.90 Prefilled Syringes Market for Oncological Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and OptimisticScenario (USD Million)
  • Table 51.91 Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.92 Prefilled Syringes Market for Cardiovascular Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and OptimisticScenario (USD Million)
  • Table 51.93 Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.94 Prefilled Syringes Market for Respiratory Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and OptimisticScenario (USD Million)
  • Table 51.95 Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.96 Prefilled Syringes Market for Neurological Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and OptimisticScenario (USD Million)
  • Table 51.97 Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.98 Prefilled Syringes Market for Metabolic Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.99 Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.100 Prefilled Syringes Market for Ophthalmic Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.101 Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.102 Prefilled Syringes Market for Orthopedic Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.103 Prefilled Syringes Market for Other Diseases, Historical Trends (2018-2022) (USD Million)
  • Table 51.104 Prefilled Syringes Market for Other Diseases, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.105 Prefilled Syringes Market: Distribution by Type of Barrel Material, 2018, 2023 and 2035 (USD Million)
  • Table 51.106 Glass Prefilled Syringes, Historical Trends (2018-2022) (USD Million)
  • Table 51.107 Glass Prefilled Syringes, Forecasted Estimates (2023-2035) Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.108 Plastic Prefilled Syringes, Historical Trends (2018-2022) (USD Million)
  • Table 51.109 Plastic Prefilled Syringes, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.110 Prefilled Syringes Market: Distribution by Number of Barrel Chamber, 2018, 2023 and 2035
  • Table 51.111 Single Chamber Prefilled Syringes, Historical Trends (2018-2022) (USD Million)
  • Table 51.112 Single Chamber Prefilled Syringes, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.113 Dual Chamber Prefilled Syringes, Historical Trends (2018-2022) (USD Million)
  • Table 51.114 Dual Chamber Prefilled Syringes Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.115 Prefilled Syringes Market: Distribution by Type of Needle System, 2018, 2023 and 2035
  • Table 51.116 Staked Needle Prefilled Syringes, Historical Trends (2018-2022) (USD Million)
  • Table 51.117 Staked Needle Prefilled Syringes, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.118 Luer Prefilled Syringes, Historical Trends (2018-2022) (USD Million)
  • Table 51.119 Luer Prefilled Syringes, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.120 Prefilled Syringes Market: Distribution by Usability of Syringe, 2018, 2023 and 2035
  • Table 51.121 Disposable Prefilled Syringes, Historical Trends (2018-2022) (USD Million)
  • Table 51.122 Disposable Prefilled Syringes, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.123 Reusable Prefilled Syringes, Historical Trends (2018-2022) (USD Million)
  • Table 51.124 Reusable Prefilled Syringes, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.125 Prefilled Syringes Market: Distribution by Type of Syringe, 2018, 2023 and 2035
  • Table 51.126 Conventional Prefilled Syringes, Historical Trends (2018-2022) (USD Million)
  • Table 51.127 Conventional Prefilled Syringes, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.128 Safety Prefilled Syringes, Historical Trends (2018-2022) (USD Million)
  • Table 51.129 Safety Prefilled Syringes, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.130 Prefilled Syringes Market: Distribution by Type of Packaging, 2018, 2023 and 2035
  • Table 51.131 Bulk Prefilled Syringes, Historical Trends (2018-2022) (USD Million)
  • Table 51.132 Bulk Prefilled Syringes, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.133 Nested Prefilled Syringes, Historical Trends (2018-2022) (USD Million)
  • Table 51.134 Nested Prefilled Syringes, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.135 Prefilled Syringes Market: Distribution by Key Geographical Regions, 2018, 2023 and 2035
  • Table 51.136 Prefilled Syringes Market for North America, Historical Trends (2018-2022) (USD Million)
  • Table 51.137 Prefilled Syringes Market for North America, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.138 Prefilled Syringes Market for Europe, Historical Trends (2018-2022) (USD Million)
  • Table 51.139 Prefilled Syringes Market for Europe, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.140 Prefilled Syringes Market for Asia-Pacific, Historical Trends (2018-2022) (USD Million)
  • Table 51.141 Prefilled Syringes Market for Asia-Pacific, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.142 Prefilled Syringes Market for Middle East and North Africa, Historical Trends (2018-2022) (USD Million)
  • Table 51.143 Prefilled Syringes Market for Middle East and North Africa, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.144 Prefilled Syringes Market for Latin America, Historical Trends (2018-2022) (USD Million)
  • Table 51.145 Prefilled Syringes Market for Latin America, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.146 Proteins Market for Blood Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.147 Proteins Market for Blood Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.148 Small Molecules Market for Blood Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.149 Small Molecules Market for Blood Disorders, Forecasted Estimates (2023-2035) (USD Million)
  • Table 51.150 Glass Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.151 Glass Prefilled Syringes Market for Blood Disorders, Forecasted Estimates (2023-2035) Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.152 Plastic Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.153 Plastic Prefilled Syringes Market for Blood Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.154 Single Chamber Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.155 Single Chamber Prefilled Syringes Market for Blood Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.156 Dual Chamber Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.157 Dual Chamber Prefilled Syringes Market for Blood Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.158 Staked Needle Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.159 Staked Needle Prefilled Syringes Market for Blood Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.160 Luer Needle Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.161 Luer Needle Prefilled Syringes Market for Blood Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.162 Disposable Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.163 Disposable Prefilled Syringes Market For Blood Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.164 Reusable Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.165 Reusable Prefilled Syringes Market For Blood Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.166 Conventional Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.167 Conventional Prefilled Syringes Market For Blood Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.168 Safety Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.169 Safety Prefilled Syringes Market For Blood Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.170 Bulk Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.171 Bulk Prefilled Syringes Market For Blood Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.172 Nested Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.173 Nested Prefilled Syringes Market For Blood Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.174 Prefilled Syringes Market for Blood Disorders in North America, Historical Trends (2018-2022) (USD Million)
  • Table 51.175 Prefilled Syringes Market for Blood Disorders in North America, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.176 Prefilled Syringes Market for Blood Disorders in Europe, Historical Trends (2018-2022) (USD Million)
  • Table 51.177 Prefilled Syringes Market for Blood Disorders in Europe, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.178 Prefilled Syringes Market for Blood Disorders in Asia-Pacific, Historical Trends (2018-2022) (USD Million)
  • Table 51.179 Prefilled Syringes Market for Blood Disorders in Asia-Pacific, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.180 Prefilled Syringes Market for Blood Disorders in Middle East and North Africa, Historical Trends (2018-2022) (USD Million)
  • Table 51.181 Prefilled Syringes Market for Blood Disorders in Middle East and North Africa, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.182 Prefilled Syringes Market for Blood Disorders in Latin America, Historical Trends (2018-2022) (USD Million)
  • Table 51.183 Prefilled Syringes Market for Blood Disorders in Latin America, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51. 184 Proteins Market for Infectious Diseases, Historical Trends (2018-2022) (USD Million)
  • Table 51.185 Proteins Market for Infectious Diseases, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.186 Vaccines Market for Infectious Diseases, Historical Trends (2018-2022) (USD Million)
  • Table 51.187 Vaccines Market for Infectious Diseases, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.188 Glass Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) (USD Million)
  • Table 51.189 Glass Prefilled Syringes Market for Infectious Diseases, Forecasted Estimates (2023-2035) Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.190 Plastic Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) (USD Million)
  • Table 51.191 Plastic Prefilled Syringes Market for Infectious Diseases, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.192 Single Chamber Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) (USD Million)
  • Table 51.193 Single Chamber Prefilled Syringes Market for Infectious Diseases, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.194 Dual Chamber Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) (USD Million)
  • Table 51.195 Dual Chamber Prefilled Syringes Market for Infectious Diseases, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.196 Staked Needle Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) (USD Million)
  • Table 51.197 Staked Needle Prefilled Syringes Market for Infectious Diseases, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.198 Luer Prefilled Syringes Market for Infectious Disease, Historical Trends (2018-2022) (USD Million)
  • Table 51.199 Luer Prefilled Syringes Market for Infectious Disease, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.200 Disposable Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) (USD Million)
  • Table 51.201 Disposable Prefilled Syringes Market for Infectious Diseases, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.202 Reusable Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) (USD Million)
  • Table 51.203 Reusable Prefilled Syringes Market for Infectious Diseases, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.204 Conventional Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) (USD Million)
  • Table 51.205 Conventional Prefilled Syringes Market for Infectious Diseases, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.206 Safety Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) (USD Million)
  • Table 51.207 Safety Prefilled Syringes Market for Infectious Diseases, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.208 Bulk Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) (USD Million)
  • Table 51.209 Bulk Prefilled Syringes Market for Infectious Diseases, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.210 Nested Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) (USD Million)
  • Table 51.211 Nested Prefilled Syringes Market for Infectious Diseases, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.212 Prefilled Syringes Market for Infectious Diseases in North America, Historical Trends (2018-2022) (USD Million)
  • Table 51.213 Prefilled Syringes Market for Infectious Diseases in North America, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.214 Prefilled Syringes Market for Infectious Diseases in Europe, Historical Trends (2018-2022) (USD Million)
  • Table 51.215 Prefilled Syringes Market for Infectious Diseases in Europe, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.216 Prefilled Syringes Market for Infectious Diseases in Asia-Pacific, Historical Trends (2018-2022) (USD Million)
  • Table 51.217 Prefilled Syringes Market for Infectious Diseases in Asia-Pacific, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.218 Prefilled Syringes Market for Infectious Diseases in Middle East and North Africa, Historical Trends (2018-2022) (USD Million)
  • Table 51.219 Prefilled Syringes Market for Infectious Diseases in Middle East and North Africa, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.220 Prefilled Syringes Market for Infectious Diseases in Latin America, Historical Trends (2018-2022) (USD Million)
  • Table 51.221 Prefilled Syringes Market for Infectious Diseases in Latin America, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.222 Proteins Market for Autoimmune Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.223 Proteins Market for Autoimmune Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.224 Antibodies Market for Autoimmune Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.225 Antibodies Market for Autoimmune Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.226 Peptides Market for Autoimmune Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.227 Peptides Market for Autoimmune Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.228 Small Molecule Market for Autoimmune Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.229 Small Molecule Market for Autoimmune Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.230 Glass Barrel Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.231 Glass Barrel Prefilled Syringes Market for Autoimmune Disorders, Forecasted Estimates (2023-2035) Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.232 Plastic Barrel Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.233 Plastic Barrel Prefilled Syringes Market for Autoimmune Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.234 Single Chamber Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.235 Single Chamber Prefilled Syringes Market for Autoimmune Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.236 Dual Chamber Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.237 Dual Chamber Prefilled Syringes Market for Autoimmune Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.238 Staked Needle Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.239 Staked Needle Prefilled Syringes Market for Autoimmune Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.240 Luer Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.241 Luer Prefilled Syringes Market for Autoimmune Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.242 Disposable Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.243 Disposable Prefilled Syringes Market for Autoimmune Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.244 Reusable Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.245 Reusable Prefilled Syringes Market for Autoimmune Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.246 Conventional Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.247 Conventional Prefilled Syringes Market for Autoimmune Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.248 Safety Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.249 Safety Prefilled Syringes Market for Autoimmune Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.250 Bulk Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.251 Bulk Prefilled Syringes Market for Autoimmune Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.252 Nested Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.253 Nested Prefilled Syringes Market for Autoimmune Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.254 Prefilled Syringes Market for Autoimmune Disorders in North America, Historical Trends (2018-2022) (USD Million)
  • Table 51.255 Prefilled Syringes Market for Autoimmune Disorders in North America, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.256 Prefilled Syringes Market for Autoimmune Disorders in Europe, Historical Trends (2018-2022) (USD Million)
  • Table 51.257 Prefilled Syringes Market for Autoimmune Disorders in Europe, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.258 Prefilled Syringes Market for Autoimmune Disorders in Asia-Pacific, Historical Trends (2018-2022) (USD Million)
  • Table 51.259 Prefilled Syringes Market for Autoimmune Disorders in Asia-Pacific, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.260 Prefilled Syringes Market for Autoimmune Disorders in Middle East and North Africa, Historical Trends (2018-2022) (USD Million)
  • Table 51.261 Prefilled Syringes Market for Autoimmune Disorders in Middle East and North Africa, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.262 Prefilled Syringes Market for Autoimmune Disorders in Latin America, Historical Trends (2018-2022) (USD Million)
  • Table 51.263 Prefilled Syringes Market for Autoimmune Disorders in Latin America, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.264 Proteins Market for Oncological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.265 Proteins Market for Oncological Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.266 Antibodies Market for Oncological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.267 Antibodies Market for Oncological Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.268 Peptides Market for Oncological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.269 Peptides Market for Oncological Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.270 Small Molecules Market for Oncological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.271 Small Molecules Market for Oncological Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.272 Vaccines Market for Oncological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.273 Vaccines Market for Oncological Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.274 Glass Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.275 Glass Prefilled Syringes Market for Oncological Disorders, Forecasted Estimates (2023-2035) Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.276 Plastic Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.277 Plastic Prefilled Syringes Market for Oncological Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.278 Single Chamber Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.279 Single Chamber Prefilled Syringes Market for Oncological Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.280 Dual Chamber Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.281 Dual Chamber Prefilled Syringes Market for Oncological Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.282 Staked Needle Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.283 Staked Needle Prefilled Syringes Market for Oncological Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.284 Luer Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.285 Luer Prefilled Syringes Market for Oncological Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.286 Disposable Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.287 Disposable Prefilled Syringes Market for Oncological Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.288 Reusable Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.289 Reusable Prefilled Syringes Market for Oncological Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.290 Conventional Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.291 Conventional Prefilled Syringes Market for Oncological Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.292 Safety Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.293 Safety Prefilled Syringes Market for Oncological Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.294 Bulk Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.295 Bulk Prefilled Syringes Market for Oncological Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.296 Nested Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.297 Nested Prefilled Syringes Market for Oncological Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.298 Prefilled Syringes Market for Oncological Disorders in North America, Historical Trends (2018-2022) (USD Million)
  • Table 51.299 Prefilled Syringes Market for Oncological Disorders in North America, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.300 Prefilled Syringes Market for Oncological Disorders in Europe, Historical Trends (2018-2022) (USD Million)
  • Table 51.301 Prefilled Syringes Market for Oncological Disorders in Europe, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.302 Prefilled Syringes Market for Oncological Disorders in Asia-Pacific, Historical Trends (2018-2022) (USD Million)
  • Table 51.303 Prefilled Syringes Market for Oncological Disorders in Asia-Pacific, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.304 Prefilled Syringes Market for Oncological Disorders in Middle East and North Africa, Historical Trends (2018-2022) (USD Million)
  • Table 51.305 Prefilled Syringes Market for Oncological Disorders in Middle East and North Africa, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.306 Prefilled Syringes Market for Oncological Disorders in Latin America, Historical Trends (2018-2022) (USD Million)
  • Table 51.307 Prefilled Syringes Market for Oncological Disorders in Latin America, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.308 Antibodies Market for Cardiovascular Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.309 Antibodies Market for Cardiovascular Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.310 Cell Therapies Market for Cardiovascular Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.311 Cell Therapies Market for Cardiovascular Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.312 Glass Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.313 Glass Prefilled Syringes Market for Cardiovascular Disorders, Forecasted Estimates (2023-2035) Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.314 Plastic Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.315 Plastic Prefilled Syringes Market for Cardiovascular Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.316 Single Chamber Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.317 Single Chamber Prefilled Syringes Market for Cardiovascular Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.318 Dual Chamber Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.319 Dual Chamber Prefilled Syringes Market for Cardiovascular Disorders Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.320 Staked Needle Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.321 Staked Needle Prefilled Syringes Market for Cardiovascular Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.322 Luer Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.323 Luer Prefilled Syringes Market for Cardiovascular Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.324 Disposable Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.325 Disposable Prefilled Syringes Market for Cardiovascular Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.326 Reusable Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.327 Reusable Prefilled Syringes Market for Cardiovascular Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.328 Conventional Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.329 Conventional Prefilled Syringes Market for Cardiovascular Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.330 Safety Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.331 Safety Prefilled Syringes Market for Cardiovascular Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.332 Bulk Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.333 Bulk Prefilled Syringes Market for Cardiovascular Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.334 Nested Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.335 Nested Prefilled Syringes Market for Cardiovascular Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.336 Prefilled Syringes Market for Cardiovascular Disorders in North America, Historical Trends (2018-2022) (USD Million)
  • Table 51.337 Prefilled Syringes Market for Cardiovascular Disorders in North America, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.338 Prefilled Syringes Market for Cardiovascular Disorders in Europe, Historical Trends (2018-2022) (USD Million)
  • Table 51.339 Prefilled Syringes Market for Cardiovascular Disorders in Europe, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.340 Prefilled Syringes Market for Cardiovascular Disorders in Asia-Pacific, Historical Trends (2018-2022) (USD Million)
  • Table 51.341 Prefilled Syringes Market for Cardiovascular Disorders in Asia-Pacific, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.342 Prefilled Syringes Market for Cardiovascular Disorders in Middle East and North Africa, Historical Trends (2018-2022) (USD Million)
  • Table 51.343 Prefilled Syringes Market for Cardiovascular Disorders in Middle East and North Africa, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.344 Prefilled Syringes Market for Cardiovascular Disorders in Latin America, Historical Trends (2018-2022) (USD Million)
  • Table 51.345 Prefilled Syringes Market for Cardiovascular Disorders in Latin America, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.346 Antibodies Market for Respiratory Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.347 Antibodies Market for Respiratory Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.348 Glass Barrel Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.349 Glass Barrel Prefilled Syringes Market for Respiratory Disorders, Forecasted Estimates (2023-2035) Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.350 Plastic Barrel Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.351 Plastic Barrel Prefilled Syringes Market for Respiratory Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.352 Single Chamber Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.353 Single Chamber Prefilled Syringes Market for Respiratory Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.354 Dual Chamber Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.355 Dual Chamber Prefilled Syringes Market for Respiratory Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.356 Staked Needle Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.357 Staked Needle Prefilled Syringes Market for Respiratory Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.358 Luer Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.359 Luer Prefilled Syringes Market for Respiratory Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.360 Disposable Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.361 Disposable Prefilled Syringes Market for Respiratory Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.362 Reusable Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.363 Reusable Prefilled Syringes Market for Respiratory Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.364 Conventional Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.365 Conventional Prefilled Syringes Market for Respiratory Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.366 Safety Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.367 Safety Prefilled Syringes Market for Respiratory Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.368 Bulk Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.369 Bulk Prefilled Syringes Market for Respiratory Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.370 Nested Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.371 Nested Prefilled Syringes Market for Respiratory Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.372 Prefilled Syringes Market for Respiratory Disorders in North America, Historical Trends (2018-2022) (USD Million)
  • Table 51.373 Prefilled Syringes Market for Respiratory Disorders in North America, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.374 Prefilled Syringes Market for Respiratory Disorders in Europe, Historical Trends (2018-2022) (USD Million)
  • Table 51.375 Prefilled Syringes Market for Respiratory Disorders in Europe, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.376 Prefilled Syringes Market for Respiratory Disorders in Asia-Pacific, Historical Trends (2018-2022) (USD Million)
  • Table 51.377 Prefilled Syringes Market for Respiratory Disorders in Asia-Pacific, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.378 Prefilled Syringes Market for Respiratory Disorders in Middle East and North Africa, Historical Trends (2018-2022) (USD Million)
  • Table 51.379 Prefilled Syringes Market for Respiratory Disorders in Middle East and North Africa, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.380 Prefilled Syringes Market for Respiratory Disorders in Latin America, Historical Trends (2018-2022) (USD Million)
  • Table 51.381 Prefilled Syringes Market for Respiratory Disorders in Latin America, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.382 Antibodies Market for Neurological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.383 Antibodies Market for Neurological Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.384 Proteins Market for Neurological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.385 Proteins Market for Neurological Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.386 Peptides Market for Neurological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.387 Peptides Market for Neurological Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.388 Small Molecules Market for Neurological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.389 Small Molecules Market for Neurological Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.390 Glass Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.391 Glass Prefilled Syringes Market for Neurological Disorders, Forecasted Estimates (2023-2035) Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.392 Plastic Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.393 Plastic Prefilled Syringes Market for Neurological Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.394 Single Chamber Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.395 Single Chamber Prefilled Syringes Market for Neurological Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.396 Dual Chamber Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.397 Dual Chamber Prefilled Syringes Market for Neurological Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.398 Staked Needle Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.399 Staked Needle Prefilled Syringes Market for Neurological Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.400 Luer Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.401 Luer Prefilled Syringes Market for Neurological Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.402 Disposable Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.403 Disposable Prefilled Syringes Market for Neurological Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.404 Reusable Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.405 Reusable Prefilled Syringes Market for Neurological Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.406 Conventional Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.407 Conventional Prefilled Syringes Market for Neurological Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.408 Safety Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.409 Safety Prefilled Syringes Market for Neurological Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.410 Bulk Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.411 Bulk Prefilled Syringes Market for Neurological Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.412 Nested Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.413 Nested Prefilled Syringes Market for Neurological Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.414 Prefilled Syringes Market for Neurological Disorders in North America, Historical Trends (2018-2022) (USD Million)
  • Table 51.415 Prefilled Syringes Market for Neurological Disorders in North America, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.416 Prefilled Syringes Market for Neurological Disorders in Europe, Historical Trends (2018-2022) (USD Million)
  • Table 51.417 Prefilled Syringes Market for Neurological Disorders in Europe, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.418 Prefilled Syringes Market for Neurological Disorders in Asia-Pacific, Historical Trends (2018-2022) (USD Million)
  • Table 51.419 Prefilled Syringes Market for Neurological Disorders in Asia-Pacific, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.420 Prefilled Syringes Market for Neurological Disorders in Middle East and North Africa, Historical Trends (2018-2022) (USD Million)
  • Table 51.421 Prefilled Syringes Market for Neurological Disorders in Middle East and North Africa, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.422 Prefilled Syringes Market for Neurological Disorders in Latin America, Historical Trends (2018-2022) (USD Million)
  • Table 51.423 Prefilled Syringes Market for Neurological Disorders in Latin America, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.424 Proteins Market for Metabolic Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.425 Proteins Market for Metabolic Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.426 Small Molecule Market for Metabolic Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.427 Small Molecule Market for Metabolic Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.428 Peptides Market for Metabolic Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.429 Peptides Market for Metabolic Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.430 Glass Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.431 Glass Prefilled Syringes Market for Metabolic Disorders, Forecasted Estimates (2023-2035) Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.432 Plastic Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.433 Plastic Prefilled Syringes Market for Metabolic Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.434 Single Chamber Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.435 Single Chamber Prefilled Syringes Market for Metabolic Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.436 Dual Chamber Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.437 Dual Chamber Prefilled Syringes Market for Metabolic Disorders Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.438 Staked Needle Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.439 Staked Needle Prefilled Syringes Market for Metabolic Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.440 Luer Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.441 Luer Prefilled Syringes Market for Metabolic Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.442 Disposable Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.443 Disposable Prefilled Syringes Market for Metabolic Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.444 Reusable Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.445 Reusable Prefilled Syringes Market for Metabolic Disorders, Forecasted Estimates (2023-2035) , Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.446 Conventional Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.447 Conventional Prefilled Syringes Market for Metabolic Disorders, Forecasted Estimates (2023-2035), Conservative, Base and Optimistic Scenario (USD Million)
  • Table 51.448 Safety Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) (USD Million)
  • Table 51.449 Safety Prefilled Syringes Market for Metabolic Disorders, Forecasted

List of Figures

  • Figure 2.1 Research Methodology: Project Methodology
  • Figure 2.2 Research Methodology: Forecast Methodology
  • Figure 2.3 Research Methodology: Robust Quality Control
  • Figure 2.4 Research Methodology: Key Market Segmentations
  • Figure 3.1 Lessons Learnt from Past Recessions
  • Figure 4.1 Executive Summary: Prefilled Syringes Market Landscape (I/II)
  • Figure 4.2 Executive Summary: Prefilled Syringes Market Landscape (I/II)
  • Figure 4.3 Executive Summary: Prefilled Syringe Combination Products Market Landscape
  • Figure 4.4 Executive Summary: Recent Developments
  • Figure 4.5 Executive Summary: Patent Analysis
  • Figure 4.6 Executive Summary: Market Forecast and Opportunity Analysis (I/II)
  • Figure 4.7 Executive Summary: Market Forecast and Opportunity Analysis (II/II)
  • Figure 5.1 Glass Barrel Prefilled Syringes: Benefits and Limitations
  • Figure 5.2 Critical Attributes of a Prefilled Syringe Design
  • Figure 5.3 Key Steps Involved in Prefilled Syringe Manufacturing
  • Figure 6.1 Prefilled Syringes: Distribution by Type of Barrel Fabrication Material
  • Figure 6.2 Prefilled Syringes: Distribution by Number of Barrel Chambers
  • Figure 6.3 Prefilled Syringes: Distribution by Type of Needle System
  • Figure 6.4 Prefilled Syringes: Distribution by Volume of Syringe
  • Figure 6.5 Prefilled Syringe Manufacturers: Distribution by Year of Establishment
  • Figure 6.6 Prefilled Syringe Manufacturers: Distribution by Company Size
  • Figure 6.7 Prefilled Syringe Manufacturers: Distribution by Location of Headquarters
  • Figure 6.8 Prefilled Syringe Manufacturers: Distribution by Company Size and Location of Headquarters
  • Figure 6.9 Prefilled Syringe Manufacturers: Distribution by Location of Manufacturing Facilities
  • Figure 6.10 Most Active Players: Distribution by Number of Prefilled Syringes
  • Figure 7.1 Product Competitiveness Analysis: Glass Barrel Prefilled Syringes
  • Figure 7.2 Product Competitiveness Analysis: Plastic Barrel Prefilled Syringes
  • Figure 8.1 Becton, Dickinson and Company: Annual Revenues, FY 2015-9M FY 2023 (USD Million)
  • Figure 8.2 Becton, Dickinson and Company: Distribution of Revenues by Business Divisions, FY 2022
  • Figure 8.3 West Pharmaceutical Services: Annual Revenues, FY 2015-H1 FY 2023 (USD Million)
  • Figure 8.4 West Pharmaceutical Services: Distribution of Revenues by Business Divisions, FY 2022
  • Figure 9.1 Gerresheimer: Annual Revenues, FY 2015-H1 FY 2023 (EUR Million)
  • Figure 9.2 Gerresheimer: Distribution of Revenues by Business Divisions, FY 2022
  • Figure 9.3 SCHOTT: Annual Revenues, FY 2015-FY 2022 (EUR Million)
  • Figure 9.4 SCHOTT: Distribution of Revenues by Business Divisions, FY 2022
  • Figure 9.5 Stevanato: Annual Revenues, FY 2020-H1 FY 2023 (EUR Million)
  • Figure 9.6 Stevanato: Distribution of Revenues by Business Divisions, FY 2022
  • Figure 11.1 Evolution of Global Healthcare Safety Legislations Across the Globe
  • Figure 12.1 Global Regulations Related to Prefilled Syringes
  • Figure 12.2 Approval Pathway for Combination Products in the US
  • Figure 12.3 Healthcare Insurance Coverage in the US: Distribution by Type of Coverage
  • Figure 12.4 Prefilled Syringes National Coverage Determination Process in the US
  • Figure 12.5 Approval Pathway for Combination Products in Canada
  • Figure 12.6 Healthcare Insurance Coverage in Canada: Distribution by Type of Coverage
  • Figure 12.7 Healthcare Insurance Coverage in the UK: Distribution by Type of Coverage
  • Figure 12.8 Reimbursement Process for Prefilled Syringes in the UK
  • Figure 12.9 Healthcare Insurance Coverage in France: Distribution by Type of Coverage
  • Figure 12.10 Reimbursement Process for Prefilled Syringes through LPPR
  • Figure 12.11 Reimbursement Process for Prefilled Syringes in Spain
  • Figure 12.12 Reimbursement Process for In-Patient Setting in Germany
  • Figure 12.13 Reimbursement Process for Out-Patient Care in Germany
  • Figure 12.14 Reimbursement Process for Prefilled Syringes in Italy
  • Figure 12.15 ` Pharmaceuticals and Prefilled Syringes Agency: Review / Approval Process
  • Figure 12.16 Snapshot of the Regulatory and Reimbursement Process in Japan
  • Figure 12.17 Healthcare Insurance Coverage in Japan: Distribution by Type of Coverage
  • Figure 12.18 Reimbursement Process for New Prefilled Syringes in Japan
  • Figure 12.19 Approval Pathway for Combination Products in China
  • Figure 12.20 Healthcare Insurance Coverage in China: Distribution by Type of Coverage
  • Figure 12.21 Reimbursement Approval Process for Prefilled Syringes in Shanghai
  • Figure 12.22 Healthcare Insurance Coverage in South Korea: Distribution by Type of Coverage
  • Figure 12.23 Healthcare Insurance Coverage in Saudi Arabia: Distribution by Type of Coverage
  • Figure 12.24 Reimbursement Process for Prefilled Syringes in Brazil
  • Figure 12.25 Healthcare Insurance Coverage in Australia: Distribution by Type of Coverage
  • Figure 13.1 Approved Prefilled Syringe Combination Products: Distribution by Type of Drug Molecule Stored
  • Figure 13.2 Approved Prefilled Syringe Combination Products: Distribution by Approval Year
  • Figure 13.3 Approved Prefilled Syringe Combination Products: Distribution by Route of Administration
  • Figure 13.4 Approved Prefilled Syringe Combination Products: Distribution by Target Therapeutic Area
  • Figure 13.5 Approved Prefilled Syringe Combination Products: Distribution by Region of Product Approval
  • Figure 13.6 Approved Prefilled Syringe Combination Products: Distribution by Other Approved Primary Packaging Systems
  • Figure 13.7 Clinical Stage Prefilled Syringe Combination Products: Distribution by Type of Drug Molecule Stored
  • Figure 13.8 Clinical Stage Prefilled Syringe Combination Products: Distribution by Phase of Development
  • Figure 13.9 Clinical Stage Prefilled Syringe Combination Products: Distribution by Route of Administration
  • Figure 13.10 Clinical Stage Prefilled Syringe Combination Products: Distribution by Target Therapeutic Area
  • Figure 13.11 Prefilled Syringe Combination Product Developers: Distribution by Year of Establishment
  • Figure 13.12 Prefilled Syringe Combination Product Developers: Distribution by Company Size
  • Figure 13.13 Prefilled Syringe Combination Product Developers: Distribution by Location of Headquarters
  • Figure 13.14 Sales of Leading Drugs Available in Prefilled Syringe Format, FY 2022 (USD Billion)
  • Figure 13.15 HUMIRA: Annual Sales, FY 2010-FY 2022 (USD Million)
  • Figure 16.1 Big Pharma Players Combination Product Portfolio: Distribution by Target Therapeutic Areas
  • Figure 16.2 Big Pharma Players Combination Product Portfolio for Autoimmune Disorders: Distribution by Stage of Development
  • Figure 16.3 Big Pharma Players Combination Product Portfolio for Autoimmune Disorders: Distribution by Target Indication
  • Figure 16.4 Big Pharma Players Combination Product Portfolio for Infectious Diseases: Distribution by Stage of Development
  • Figure 16.5 Big Pharma Players Combination Product Portfolio for Infectious Diseases: Distribution by Target Indication
  • Figure 16.6 Big Pharma Players Combination Product Portfolio for Neurological Disorders: Distribution by Stage of Development
  • Figure 16.7 Big Pharma Players Combination Product Portfolio for Neurological Disorders: Distribution by Target Indication
  • Figure 16.8 Big Pharma Players Combination Product Portfolio for Blood Disorders: Distribution by Stage of Development
  • Figure 16.9 Big Pharma Players Combination Product Portfolio for Blood Disorders: Distribution by Target Indication
  • Figure 16.10 Big Pharma Players Combination Product Portfolio for Oncological Disorders: Distribution by Stage of Development
  • Figure 16.11 Big Pharma Players Combination Product Portfolio for Oncological Disorders: Distribution by Target Indication
  • Figure 16.12 Big Pharma Players Combination Product Portfolio: Distribution by Type of Molecule
  • Figure 16.13 Big Pharma Players Combination Product Portfolio for Antibodies: Distribution by Stage of Development
  • Figure 16.14 Big Pharma Players Combination Product Portfolio Vaccines: Distribution by Stage of Development
  • Figure 16.15 Big Pharma Players Combination Product Portfolio Proteins: Distribution by Stage of Development
  • Figure 16.16 Big Pharma Players Combination Product Portfolio Peptides: Distribution by Stage of Development
  • Figure 16.17 Big Pharma Players Combination Product Portfolio Small Molecules: Distribution by Stage of Development
  • Figure 16.18 Big Pharma Players Combination Product Portfolio Other Biologics: Distribution by Stage of Development
  • Figure 17.1 Recent Developments: Cumulative Year-wise Trend, 2019-2023
  • Figure 17.2 Recent Developments: Distribution by Type of Initiative
  • Figure 17.3 Recent Developments: Distribution by Year and Type of Initiative
  • Figure 17.4 Recent Developments: Distribution by Type of Expansion
  • Figure 17.5 Recent Developments: Distribution by Location of Expansion
  • Figure 17.6 Recent Developments: Distribution by Type of Partnership
  • Figure 17.7 Recent Developments: Distribution by Geography
  • Figure 17.8 Most Active Players: Distribution by Number of Recent Initiatives
  • Figure 17.9 Most Active Players: Distribution by Type of Initiatives
  • Figure 18.1 Patent Analysis: Distribution by Type of Patent
  • Figure 18.2 Patent Analysis: Cumulative Distribution by Patent Publication Year, 2019 - 2023
  • Figure 18.3 Patent Analysis: Distribution by Type of Patent and Publication Year
  • Figure 18.4 Patent Analysis: Distribution by Patent Application Year, Pre-2014 - 2023
  • Figure 18.5 Patent Analysis: Distribution by Patent Jurisdiction
  • Figure 18.6 Patent Analysis: Distribution by CPC Symbols
  • Figure 18.7 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant, 2019-2023
  • Figure 18.8 Leading Players: Distribution by Number of Patents
  • Figure 18.9 Leading Individual Assignees: Distribution by Number of Patents
  • Figure 18.10 Patent Benchmarking Analysis: Distribution of Leading Players by Patent Characteristics (CPC Codes)
  • Figure 18.11 Patent Analysis: Distribution by Patent Age
  • Figure 18.12 Prefilled Syringes: Patent Valuation
  • Figure 19.1 Prefilled Syringes KOL Analysis: Distribution by Role of KOL
  • Figure 19.2 Prefilled Syringes KOL Analysis: Distribution by Type of Sponsor Organization
  • Figure 19.3 Prefilled Syringes KOL Analysis: Distribution by Affiliated Organization
  • Figure 19.4 Prefilled Syringes KOL Analysis: Distribution by Target Disease Indication
  • Figure 19.5 Prefilled Syringes KOL Analysis: Distribution by Geographical Location
  • Figure 19.6 Prefilled Syringes Most Prominent KOLs: Distribution by Activeness, Expertise and Strength of KOL
  • Figure 19.7 Prefilled Syringes Most Prominent KOLs: Distribution by RA Score
  • Figure 22.1 Diabetes: Geographical Prevalence and Mortality, 2021 (in Millions)
  • Figure 23.1 Prefilled Syringes: SWOT Analysis
  • Figure 23.2 Prefilled Syringe Recalls: Distribution by Reason of Recall, 2003-2023
  • Figure 23.3 Comparison of SWOT Factors: Harvey Ball Analysis
  • Figure 24.1 Global Prefilled Syringes Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 24.2 Global Prefilled Syringes Market, Forecasted Estimates (2023-2035): Conservative Scenario (USD Million)
  • Figure 24.3 Global Prefilled Syringes Market, Forecasted Estimates (2023-2035): Optimistic Scenario (USD Million)
  • Figure 25.1 Prefilled Syringes Market: Distribution by Purpose of Prefilled Syringe, 2018, 2023 and 2035
  • Figure 25.2 Specialty Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 25.3 Therapeutic Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 25.4 Cosmetic Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 26.1 Prefilled Syringes Market: Distribution by Type of Molecule, 2018, 2023 and 2035
  • Figure 26.2 Prefilled Syringes Market for Proteins: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 26.3 Prefilled Syringes Market for Antibodies: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 26.4 Prefilled Syringes Market for Peptides: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 26.5 Prefilled Syringes Market for Small Molecules: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 26.6 Prefilled Syringes Market for Vaccines: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 26.7 Prefilled Syringes Market for Cell Therapies: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 27.1 Prefilled Syringes Market: Distribution by Target Therapeutic Area, 2018, 2023 and 2035
  • Figure 27.2 Prefilled Syringes Market for Blood Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 27.3 Prefilled Syringes Market for Infectious Diseases: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 27.4 Prefilled Syringes Market for Autoimmune Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 27.5 Prefilled Syringes Market for Oncological Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 27.6 Prefilled Syringes Market for Cardiovascular Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 27.7 Prefilled Syringes Market for Respiratory Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 27.8 Prefilled Syringes Market for Neurological Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 27.9 Prefilled Syringes Market for Metabolic Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 27.10 Prefilled Syringes Market for Ophthalmic Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 27.11 Prefilled Syringes Market for Orthopedic Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 27.12 Prefilled Syringes Market for Other Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 28.1 Prefilled Syringes Market: Distribution by Type of Barrel Material, 2018, 2023 and 2035
  • Figure 28.2 Glass Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 28.3 Plastic Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 29.1 Prefilled Syringes Market: Distribution by Number of Barrel Chamber, 2018, 2023 and 2035
  • Figure 29.2 Single Chamber Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 29.3 Dual Chamber Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 30.1 Prefilled Syringes Market: Distribution by Type of Needle System, 2018, 2023 and 2035
  • Figure 30.2 Staked Needle Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 30.3 Luer Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 31.1 Prefilled Syringes Market: Distribution by Usability of Syringe, 2018, 2023 and 2035
  • Figure 31.2 Disposable Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 31.3 Reusable Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 32.1 Prefilled Syringes Market: Distribution by Type of Syringe, 2018, 2023 and 2035
  • Figure 32.2 Conventional Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 32.3 Safety Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 33.1 Prefilled Syringes Market: Distribution by Type of Packaging, 2018, 2023 and 2035
  • Figure 33.2 Bulk Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 33.3 Nested Prefilled Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 34.1 Prefilled Syringes Market: Distribution by Key Geographical Regions, 2018, 2023 and 2035
  • Figure 34.2 Prefilled Syringes Market in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 34.3 Prefilled Syringes Market in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 34.4 Prefilled Syringes Market in Asia-Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 34.5 Prefilled Syringes Market in Middle East and North Africa Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 34.6 Prefilled Syringes Market in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 35.1 Proteins Market for Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 35.2 Small Molecules Market For Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 35.3 Glass Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 35.4 Plastic Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 35.5 Single Chamber Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 35.6 Dual Chamber Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 35.7 Staked Needle Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 35.8 Luer Needle Prefilled Syringes Market for Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 35.9 Disposable Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 35.10 Reusable Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 35.11 Conventional Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 35.12 Safety Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 35.13 Bulk Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 35.14 Nested Prefilled Syringes Market For Blood Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 35.15 Prefilled Syringes Market for Blood Disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 35.16 Prefilled Syringes Market for Blood Disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 35.17 Prefilled Syringes Market for Blood Disorders in Asia-Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 35.18 Prefilled Syringes Market for Blood Disorders in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 35.19 Prefilled Syringes Market for Blood Disorders in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 36.1 Proteins Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 36.2 Vaccines Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 36.3 Glass Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 36.4 Plastic Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 36.5 Single Chamber Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 36.6 Dual Chamber Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 36.7 Staked Needle Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 36.8 Luer Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 36.9 Disposable Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 36.10 Reusable Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 36.11 Conventional Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 36.12 Safety Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 36.13 Bulk Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 36.14 Nested Prefilled Syringes Market for Infectious Diseases, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 36.15 Prefilled Syringes Market for Infectious Diseases in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 36.16 Prefilled Syringes Market for Infectious Diseases in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 36.17 Prefilled Syringes Market for Infectious Diseases in Asia-Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 36.18 Prefilled Syringes Market for Infectious Diseases in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 36.19 Prefilled Syringes Market for Infectious Diseases in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 37.1 Proteins Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 37.2 Antibodies Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 37.3 Peptides Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 37.4 Small Molecule Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 37.5 Glass Barrel Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 37.6 Plastic Barrel Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 37.7 Single Chamber Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 37.8 Dual Chamber Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 37.9 Staked Needle Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 37.10 Luer Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 37.11 Disposable Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 37.12 Reusable Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 37.13 Conventional Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 37.14 Safety Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 37.15 Bulk Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 37.16 Nested Prefilled Syringes Market for Autoimmune Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 37.17 Prefilled Syringes Market for Autoimmune Disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 37.18 Prefilled Syringes Market for Autoimmune Disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 37.19 Prefilled Syringes Market for Autoimmune Disorders in Asia-Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 37.20 Prefilled Syringes Market for Autoimmune Disorders in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 37.21 Prefilled Syringes Market for Autoimmune Disorders in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.1 Proteins Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.2 Antibodies Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.3 Peptides Market for Oncological Disorders, Historical Trends (2020-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.4 Small Molecules Market for Oncological Disorders, Historical Trends (2020-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.5 Vaccines Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.6 Glass Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.7 Plastic Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.8 Single Chamber Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.9 Dual Chamber Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.10 Staked Needle Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.11 Luer Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.12 Disposable Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.13 Reusable Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.14 Conventional Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.15 Safety Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.16 Bulk Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.17 Nested Prefilled Syringes Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.18 Prefilled Syringes Market for Oncological Disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.19 Prefilled Syringes Market for Oncological Disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.20 Prefilled Syringes Market for Oncological Disorders in Asia-Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.21 Prefilled Syringes Market for Oncological Disorders in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 38.22 Prefilled Syringes Market for Oncological Disorders in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 39.1 Antibodies Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 39.2 Cell Therapies Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 39.3 Glass Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 39.4 Plastic Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 39.5 Single Chamber Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 39.6 Dual Chamber Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 39.7 Staked Needle Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 39.8 Luer Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 39.9 Disposable Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 39.10 Reusable Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 39.11 Conventional Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 39.12 Safety Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 39.13 Bulk Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 39.14 Nested Prefilled Syringes Market for Cardiovascular Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 39.15 Prefilled Syringes Market for Cardiovascular Disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 39.16 Prefilled Syringes Market for Cardiovascular Disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 39.17 Prefilled Syringes Market for Cardiovascular Disorders in Asia-Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 39.18 Prefilled Syringes Market for Cardiovascular Disorders in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 39.19 Prefilled Syringes Market for Cardiovascular Disorders: Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 40.1 Antibodies Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 40.2 Glass Barrel Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 40.3 Plastic Barrel Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 40.4 Single Chamber Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 40.5 Dual Chamber Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 40.6 Staked Needle Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 40.7 Luer Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 40.8 Disposable Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 40.9 Reusable Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 40.10 Conventional Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 40.11 Safety Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 40.12 Bulk Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 40.13 Nested Prefilled Syringes Market for Respiratory Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 40.14 Prefilled Syringes Market for Respiratory Disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 40.15 Prefilled Syringes Market for Respiratory Disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 40.16 Prefilled Syringes Market for Respiratory Disorders in Asia-Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 40.17 Prefilled Syringes Market for Respiratory Disorders in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 40.18 Prefilled Syringes Market for Respiratory Disorders in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 41.1 Antibodies Market for Neurological Disorders, Historical Trends (2020-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 41.2 Proteins Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 41.3 Peptides Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 41.4 Small Molecules Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 41.5 Glass Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 41.6 Plastic Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 41.7 Single Chamber Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 41.8 Dual Chamber Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 41.9 Staked Needle Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 41.10 Luer Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 41.11 Disposable Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 41.12 Reusable Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 41.13 Conventional Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 41.14 Safety Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 41.15 Bulk Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 41.16 Nested Prefilled Syringes Market for Neurological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 41.17 Prefilled Syringes Market for Neurological Disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 41.18 Prefilled Syringes Market for Neurological Disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 41.19 Prefilled Syringes Market for Neurological Disorders in Asia-Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 41.20 Prefilled Syringes Market for Neurological Disorders in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 41.21 Prefilled Syringes Market for Neurological Disorders in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 42.1 Proteins Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 42.2 Small Molecule Market for Metabolic Disorders, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 42.3 Peptides Market for Metabolic Disorders, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 42.4 Glass Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 42.5 Plastic Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 42.6 Single Chamber Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 42.7 Dual Chamber Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 42.8 Staked Needle Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 42.9 Luer Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 42.10 Disposable Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 42.11 Reusable Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 42.12 Conventional Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 42.13 Safety Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 42.14 Bulk Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 42.15 Nested Prefilled Syringes Market for Metabolic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 42.16 Prefilled Syringes Market for Metabolic Disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 42.17 Prefilled Syringes Market for Metabolic Disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 42.18 Prefilled Syringes Market for Metabolic Disorders in Asia-Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 42.19 Prefilled Syringes Market for Metabolic Disorders in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 42.20 Prefilled Syringes Market for Metabolic Disorders in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 43.1 Proteins Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 43.2 Antibodies Market for Ophthalmic Disorders, Historical Trends (20-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 43.3 Glass Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 43.4 Plastic Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 43.5 Single Chamber Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 43.6 Dual Chamber Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 43.7 Staked Needle Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 43.8 Luer Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 43.9 Disposable Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 43.10 Reusable Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 43.11 Conventional Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 43.12 Safety Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 43.13 Bulk Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 43.14 Nested Prefilled Syringes Market for Ophthalmic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 43.15 Prefilled Syringes Market for Ophthalmic Disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 43.16 Prefilled Syringes Market for Ophthalmic Disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 43.17 Prefilled Syringes Market for Ophthalmic Disorders in Asia-Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 43.18 Prefilled Syringes Market for Ophthalmic Disorders in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 43.19 Prefilled Syringes Market for Ophthalmic Disorders in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 44.1 Antibodies Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 44.2 Small Molecules Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 44.3 Cell Therapies Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 44.4 Glass Barrel Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 44.5 Plastic Barrel Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 44.6 Single Chamber Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 44.7 Dual Chamber Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 44.8 Staked Needle Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 44.9 Luer Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 44.10 Disposable Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 44.11 Reusable Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 44.12 Conventional Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 44.13 Safety Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 44.14 Bulk Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 44.15 Nested Prefilled Syringes Market for Orthopedic Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 44.16 Prefilled Syringes Market for Orthopedic Disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 44.17 Prefilled Syringes Market for Orthopedic Disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 44.18 Prefilled Syringes Market for Orthopedic Disorders in Asia-Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 44.19 Prefilled Syringes Market for Orthopedic Disorders in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 44.20 Prefilled Syringes Market for Orthopedic Disorders in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.1 Proteins Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.2 Antibodies Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.3 Peptides Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.4 Small Molecules Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.5 Vaccines Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.6 Cell Therapies Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.7 Glass Barrel Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.8 Plastic Barrel Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.9 Single Chamber Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.10 Dual Chamber Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.11 Staked Needle Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.12 Luer Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.13 Disposable Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.14 Reusable Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.15 Conventional Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.16 Safety Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.17 Bulk Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.18 Nested Prefilled Syringes Market for Other Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.19 Prefilled Syringes Market for Other Disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.20 Prefilled Syringes Market for Other Disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.21 Prefilled Syringes Market for Other Disorders in Asia-Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.22 Prefilled Syringes Market for Other Disorders in Middle East and North Africa, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 45.23 Prefilled Syringes Market for Other Disorders in Latin America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Figure 46.1 West Pharmaceutical Services: Annual Revenues, FY 2015-FY H1 2023 (USD Million)
  • Figure 46.2 West Pharmaceutical Services: Distribution of Revenues by Business Divisions, FY 2022
  • Figure 46.3 Datwyler: Annual Revenues, FY 2015-FY H1 2023 (CHF Billion)
  • Figure 46.4 Aptar Pharma: Annual Revenues, FY 2015-FY H1 2023 (USD Billion)
  • Figure 46.5 Stevanato: Annual Revenues, FY 2020-H1 FY 2023 (EUR Million)
  • Figure 46.6 Stevanato: Distribution of Revenues by Business Divisions, FY 2022
  • Figure 47.1 Prefilled Syringe: Steps Involved in Fill / Finish Process
  • Figure 47.2 Prefilled Syringe Fill / Finish Service Providers: Distribution by Year of Establishment
  • Figure 47.3 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Headquarters and Type of Drug Molecule Filled
  • Figure 47.4 Prefilled Syringe Fill / Finish Service Providers: Distribution by Scale of Operation
  • Figure 48.1 Autoject Micro: Mechanism of Drug Delivery
  • Figure 48.2 Autoject 2 Autoinjector: Mechanism of Drug Delivery
  • Figure 48.3 Autoject Mini: Mechanism of Drug Delivery
  • Figure 48.4 Elcam Medical: Product Portfolio
  • Figure 48.5 Flexi-Q PFS: Components
  • Figure 48.6 Flexi-Q PFS: Mechanism of Drug Delivery
  • Figure 48.7 Flexi-Q DV: Components
  • Figure 48.8 Flexi-Q DV: Mechanism of Drug Delivery
  • Figure 48.9 Flexi-Q EAI: Mechanism of Drug Delivery
  • Figure 48.10 Flexi-Q mMU: Components
  • Figure 48.11 Flexi-Q eMU: Components
  • Figure 48.12 Flexi-Q mMU / Flexi-Q eMU: Mechanism of Drug Delivery
  • Figure 48.13 Union Medico: 45?Autoinjector Portfolio
  • Figure 48.14 45?/R Autoinjector: Components
  • Figure 48.15 Types of 45?/R Autoinjectors
  • Figure 48.16 Types of 90? Autoinjectors
  • Figure 48.17 Exclusive Autoinjectors: Components
  • Figure 48.18 SHL Medical: Product Portfolio
  • Figure 48.19 SHL Medical: Prefilled Syringe based Autoinjectors
  • Figure 48.20 SHL Medical: Cartridge based Autoinjectors
  • Figure 48.21 SHL Medical: Two-Step Autoinjectors
  • Figure 48.22 SHL Medical Two-Step Autoinjectors: Mechanism of Drug Delivery
  • Figure 48.23 Ypsomed: Annual Revenues, FY 2014 - H1 FY 2023 (CHF Million)
  • Figure 48.24 Ypsomed: Sales by Business Divisions, 2022 (CHF Million)
  • Figure 48.25 YpsoMate: Mechanism of Drug Delivery
  • Figure 48.26 VarioJect: Mechanism of Drug Delivery
  • Figure 49.1 Concluding Remarks: Prefilled Syringes Market Landscape
  • Figure 49.2 Concluding Remarks: Prefilled Syringe Combination Products Market Landscape
  • Figure 49.3 Concluding Remarks: Recent Developments
  • Figure 49.4 Concluding Remarks: Patent Analysis
  • Figure 49.5 Concluding Remarks: KOL Analysis
  • Figure 49.6 Concluding Remarks: Market Forecast and Opportunity Analysis (I/III)
  • Figure 49.7 Concluding Remarks: Market Forecast and Opportunity Analysis (II/III)
  • Figure 49.8 Concluding Remarks: Market Forecast and Opportunity Analysis (III/III)